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Ein großer Teil dessen, was Menschen
Intelligenz nennen, ist am Ende Neugierde.
- Aaron Swartz -
Zusammenfassung
Ein Ziel der biomolekularen Modellierung ist die Berechnung der Aﬃnität
∆G von Liganden an Proteine, insbesondere Enzyme. Das Spektrum der
Methoden, die zu diesem Zweck entwickelt wurden, reicht von theoretisch
genauen aber aufwändigen Verfahren zu einfachen, eher qualitativen Ver-
fahren. Während letztere häuﬁg empirische Scoring-Funktionen und eine
einzelne Struktur als Eingabe verwenden, wird für kompliziertere Metho-
den der möglichst vollständige Konformationsraum eines Protein-Ligand-
Komplexes benötigt. Dieser wird mit Sampling-Verfahren wie der Moleku-
lardynamik (MD) durchmustert.
In dieser Promotionsarbeit sollten Verfahren zur Berechnung von ∆G, ins-
besondere Varianten der Molecular Mechanics Poisson-Boltzmann Surface
Area (MMPBSA) Methode, getestet und nach Möglichkeit weiterentwickelt
werden. Desweiteren sollte die Auswirkung bestimmter Resistenzmutationen
auf Struktur und Dynamik von Proteinen mit unterschiedlichen Maßen aus
MD Simulationen heraus erfasst werden.
Der erste Schritt der quantitativen Modellierung mit MD ist die Beschrei-
bung der Moleküle durch die Parametrisierung eines Kraftfelds. Anhand
des sulfatierten Tyrosins wurde eine solche molekulare Parametrisierung für
ein Nicht-Standard-Molekül durchgeführt. Sodann wurden Varianten der
tendenziell weniger aufwändigen MMPBSA-Methode getestet im Hinblick
auf ihre Konvergenz und ihre Eignung zur Bestimmung genauer ∆G-Werte
oder zumindest verschiedene Enzym-Ligand-Komplexe in eine richtige Rang-
folge gemäß ihrer ∆G-Werte zu bringen. Die Varianten unterscheiden sich
durch verschiedene Solvatisierungsmodelle und Methoden zur Berechnung
der Entropie. Als molekulares Referenzsystem wurden Mutanten der HIV-
Protease im Komplex mit Wirkstoﬀen verwendet, da es hierzu experimentelle
Daten gibt, mit denen die berechneten Werte verglichen werden können.
Am anderen Ende des methodischen Spektrums liegt die aufwändige Ther-
modynamische Integration (TI). Bei einer guten Kraftfeldparametrisierung
sollte TI in der Lage sein, ∆G-Eﬀekte in der Größenordnung weniger kJ/mol
quantitativ zu bestimmen. Dies wurde anhand der Mutante L76V der HIV-
Protease, die für einige Wirkstoﬀe zu einer Resensitivierung (erhöhte Aﬃnität)
führt, getestet. Schließlich sollten MD-Simulationen verwendet werden, um
die molekularen Eﬀekte von Mutationen der NS3/4A-Protease des humanen
Hepatitis C Virus auf die Bindung von Liganden (Substrat, Inhibitoren) zu
verstehen.
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Abstract
A major aim of biomolecular modelling is the calculation of binding aﬃnities
∆G of ligands to proteins, especially enzymes. The spectrum of methods
that has been developed for this task ranges from theoretically exact but
expensive to more simple and qualitative ones. While the latter are often
empirical scoring functions using one single structure as an input, the more
complex methods require the preferably complete conformational space of a
protein-ligand complex which can be sampled using methods such as molec-
ular dynamics (MD).
The intention of this thesis was to test and further develop methods for
the calculation of ∆G, in particular variants of the molecular mechanics
Poisson-Boltzmann surface area (MMPBSA) method. Furthermore, the ef-
fects of speciﬁc resistance mutations on the structure and dynamics of pro-
teins should be determined using diﬀerent metrics on MD simulation data.
The ﬁrst step to quantitative modelling using MD is the description of the
molecules by parameterizing a forceﬁeld. Such a molecular parameteriza-
tion was performed for the non-standard amino acid sulpho-tyrosine. Sub-
sequently, variants of the less expensive MMPBSA method were tested with
regard to their ability to converge and determine ∆G estimates or at least
establish the correct ranking of ∆G values for a set of enzyme-ligand com-
plexes. Diﬀerent solvation models and procedures to calculate the entropy
have been used. As a molecular reference system, mutants of the HIV pro-
tease complexed with inhibitors were used. For these systems, experimental
data are available to which the calculated values can be compared. At the
other end of the methodological spectrum is the more expensive thermody-
namic integration (TI). With a proper forceﬁeld parameterization, TI should
be able to quantitatively determine ∆G eﬀects in the order of a few kJ/mol.
This was tested on the HIV protease mutation L76V which is known to lead
to a resensitivation (increased aﬃnity) for some drugs. Eventually, MD sim-
ulations were used to understand the molecular eﬀects of mutations of the
NS3/4A protease, an enzyme of the human hepatitis C virus, on the binding
of ligands (substrate, inhibitors).
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1 Introduction
1.1 HIV and HCV Epidemiology
According to the world health organization (WHO), in 2010, an estimated 34
million people worldwide were living with AIDS and 2.7 million were newly
infected. Due to the availability of antiretroviral therapy (ART) the number
of people dying from AIDS-related causes could be reduced from 2.2 million
in 2005 down to 1.8 million in 2010 [1].
170 Mio people worldwide are infected with HCV, and the number is ex-
pected to increase dramatically in the next decade. In most cases (6085%)
the HCV infection progresses to chronic liver disease and eventually to liver
cirrhosis and hepatocarcinoma [2]. The presently applied combination ther-
apy with pegylated interferon-α together with Ribavirin is costly, prolonged
and it is associated with severe side eﬀects [3]. This therapy is able to erad-
icate the virus in approximately 80% for genotype 2, but only 50% cases of
genotype 1 infected patients. Unfortunately, 70-80% in the United States
and more than 60% in Europe and Asian are infected with genotype 1 mak-
ing the current standard of care unsatisfactory for many of these patients.
There is hence an urgent need for additional and in particular directly acting
antiviral agents that target speciﬁc stages in the viral life cycle.
Figure 1.1: Structure of HIV. Left) Schematic representation of the
HIV virion (source: National Institute of Allergy and Infectious Diseases
(NIAID) [4]). Right) Cryo-electron microscopic image of mature HIV parti-
cles (source: Briggs et al. [5]).
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The HIV virion particle is around 120 nm in diameter and has a roughly
spherical shape. It has an outer coat, the viral envelope, that is composed
of two lipid layers taken from the host cell membrane when a newly formed
virus particle buds from the cell (ﬁgure 1.1). A various number of envelope
proteins spike through its surface that consist of a cap made of three glyco-
proteins 120 (gp120) proteins and a stem of three glycoproteins 41 (gp41)
which anchor the structure in the envelope. Inside that envelope, there is a
cone-shaped core made up of roughly 2000 p24 proteins . Inside this core (or
capsid), there are two copies of single-stranded RNA tightly bound to the
nucleocapsid proteins p6 and p7 together with an arsenal of viral proteins
needed for replication, most importantly the reverse transcriptase, integrase
and protease.
A schematic representation of the HIV life cycle is depicted in ﬁgure 1.2 [6].
HIV speciﬁcally infects human T-cells, but other cells like macrophages or
monocytes can also be used as hosts for viral replication [7]. The virion is
directed towards the CD4+ immune cells where its envelope proteins gp120
interact with the CD4 receptor. Additional interactions with one of the two
chemokine receptors CCR5 or CXCR4 induce a conformational rearrange-
ment in the HIV envelope leading to exposure of a hydrophobic domain on
gp41 and the viral membrane in turn fuses with the cell membrane. The
fusion process and viral entry induce uncoating of the viral core. Viral RNA
and proteins are released into the cell, and the RNA is translated into DNA
by the reverse transcriptase. The viral integrase inserts this DNA into the
host cell genome. The cellular machinery initiates transcription into mRNA
and produces the viral precursor proteins gag and gag-pol. In the following,
these proteins diﬀuse to the cell membrane and the formation of new imma-
ture virus particles takes place. The precursor peptides are then cleaved at
certain sites in a deﬁned order by the HIV protease to yield mature virus
particles.
2
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Figure 1.2: The HIV Lifecycle. Source: National Institute of Allergy
and Infectious Diseases (NIAID) [4].
1.3 Antiviral Drugs and Resistance
Since the discovery of the human immunodeﬁciency virus (HIV) in 1983,
several classes of drugs have been developed targeting viral entry, reverse
transcription and in particular the maturation process by inhibiting the pro-
tease. The ﬁrst protease inhibitor developed by Roche and approved by the
food and drug administration (FDA) in 1995, saquinavir (SQV), mimics the
intermediate state of the proteases natural substrate. Consequently, it in-
hibits protease activity by binding into the active site. Up to the present,
nine protease inhibitors have been developed and this class of inhibitors con-
3
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tinues to be the most eﬀective class of HIV drugs. However, HIV recovers
frequently its activity by developing resistance mutations. These mutations
lead to a loss of drug binding aﬃnity. It is therefore important to under-
stand the structural mechanism of these resistance mutations to be able to
construct new eﬀective drugs. Since the introduction of the protease in-
hibitors, patients are treated with a combination of three drugs on average
(highly active antiretroviral therapy, HAART) in order to avoid the devel-
opment of resistant virus strains. On the annual Arevir Meeting in Bonn
(www.genafor.org), clinicians and computer scientists meet to discuss most
recent advances in the ﬁeld of HIV diagnosis and therapy. One major topic
there is the prediction of drug resistance that is used to guide clinicians with
the compilation of their treatment regimes. These predictions are based on
sequence data and diﬀerent machine learning algorithms are adopted, e.g.
decision trees [8], to predict the susceptibility to speciﬁc drugs from geno-
type. Whereas these systems serve very well for decision making, they have
their limitations. In particular, these systems are knowledge-based and can
therefore only predict mutations that have already been observed. Hence,
resistance to newly developed drugs cannot be predicted without producing
experimental data. These methods have recently been signiﬁcantly improved
by incorporating structural descriptors like the electrostatic potential in com-
bination with hydrophobicity [9]. Because phenotypic resistance assays are
time-consuming and costly, and genotypic rules-based interpretations may
also fail to predict the eﬀects of multiple mutations, a desirable goal of com-
putational chemistry is the structure-based phenotype prediction [10], where
the binding aﬃnity of established drugs to the protease is calculated from a
model based on available crystal structures.
The variety of resistance mechanisms is large. The major resistance mu-
tations are typically located directly in the binding cavity with eﬀects like
contact losses, steric clashes, or alteration of hydrophobic clusters [11]. Other
resistance mutations are more far oﬀ the active site and inﬂuence inhibitor
binding by indirect geometric rearrangements or changes in ﬂexibility [12].
Also more special mechanisms exist like the weakening of dimerization energy
of the two HIV protease monomers [13].
The emergence of resistance is a trade-oﬀ of ligand binding loss and the
balance of substrate processing eﬃciency. A paradigm that emerged over
the last 10 years is the substrate envelope hypothesis [14]. Its message is
that inhibitors that protrude from the substrate envelope, a representation
of the consensus volume of the proteases natural substrates, are markedly
more prone to the emergence of resistance mutations than inhibitors that
stay within the envelope. The hypothesis has been proven to explain several
major resistance mutations for both HIV and HCV proteases [15, 16] and it
is already in use as a design paradigm for new protease inhibitors [17] that
will be less prone to resistance.
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Experiments for the discovery of new drugs are very time-consuming and
expensive tasks [18]. Especially, the chemical synthesis of new drug candi-
dates can be very laborious. It is therefore desirable to have computational
methods that can substitute for at least some of these experiments. Gener-
ally, the accurate and eﬃcient calculation of the free energy of drug-target
binding is a major goal of computational chemistry. Simple approximate
computational methods, that are able to distinguish very weak binders from
those that are possibly strong binders, are already in commercial use. It
is however not possible to determine the binding aﬃnity reliably without
a full dynamical picture of a protein-drug complex. Hence, as computer
power increases and forceﬁelds become more accurate, molecular dynamics
is a promising tool for drug design and can be expected to be used on a
routine basis in future times [19, 20, 21]. For the development of a new
drug, it would also be helpful to know the structural details of binding such
as entropic or enthalpic energetics, van der Waals and electrostatic interac-
tions. The molecular mechanics Poisson-Boltzmann surface area approach
(MMPBSA) can in principle provide a residue-wise energetic decomposition
giving clues for drug modiﬁcations that improve binding or make it less prone
to resistance mutations. This has already quite often been done in the liter-
ature [22, 23, 24, 25].
The major concern of this thesis is to further improve and establish new
strategies to understand resistance mutations on an energetic and mechanis-
tic basis using molecular dynamics simulations.
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In the following chapter, I explain the theoretical concepts that are utilized
within this thesis. The intention is to present a consistent picture in general.
Therefore, some concepts are treated only in brief while other concepts of
particular relevance are explained in higher computational detail.
Starting from quantum mechanics and its approximations, concepts of molec-
ular mechanics and dynamics will be explained, followed by a section on
advanced sampling strategies. Since needed for MMPBSA type free energy
calculations, continuum solvation models and the calculation of conforma-
tional entropy based on normal modes are also explained in more detail.
2.1 Molecular Mechanics
To calculate medically relevant macroscopic properties one requires a proper
physical description of the molecular system. The description has to be
detailed enough to yield accurate quantitative results and must be compu-
tationally feasible.
2.1.1 From Quantum to Molecular Mechanics
In principle, the state of any molecular system is exactly described by a wave
function ψ that satisﬁes the time-independent Schrödinger equation
Hψ = Eψ (2.1)
where E is the energy and the Hamilton operator H is a structured opera-
tor describing the system in a formal fashion. It contains functions of the
electronic and nucleic coordinates. This equation has analytical solutions
only for simple systems such as the hydrogen atom and its solution has to
be approximated for systems with more than a few atoms.
A commonly used simpliﬁcation, the Born-Oppenheimer approximation, as-
sumes that the motions of the electrons are directly coupled to the motions
of the nuclei. This is reasonable because the mass of an electron is more than
three orders of magnitude smaller than the mass of a nucleus. The kinetic
energy of the electrons is therefore neglected.
A further simpliﬁcation assumes that every single electron moves in the av-
erage ﬁeld of all other electrons producing a self-consistent ﬁeld (SCF). This
is described by the Hartree-Fock equation. It can be used to calculate the
molecular electrostatic potential (MEP). The MEP is used to calculate par-
tial atomic point charges for empirical forceﬁelds used in molecular dynamics
simulations. Practically, the Hartree-Fock method is suited to approximate
the Schrödinger equation for at most some hundreds of atoms.
Since it is not feasible to calculate the electronic structure for macromolecules
with high accuracy by means of any type of quantum chemistry calculations,
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most practical simulations use a set of simple classical functions to represent
the energy, adjusting a large number of parameters to optimize agreement
with experimental data and with quantum calculations on smaller molecules.
The system can then be described with Newtonian mechanics.
2.1.2 Molecular Dynamics
The time evolution of a molecular system can be simulated by integrating
Newtons equation of motion
~Fi =
δV
δ~ri
= mi
d2~ri
dt2
(2.2)
where mi and ~ri are the mass and position of particle i, respectively, Fi is
the force acting on particle i and V is the potential energy function of the
system. The potential energy is determined by the force ﬁeld (subsection
2.1.3). The integration is carried out in a step-wise fashion where the time is
discretized into time steps usually in the range of 1-2 femtoseconds. Several
algorithms exist for this integration procedure [26]. In the Amber Molecular
Dynamics Software, the leapfrog algorithm is used [27]. In this algorithm,
velocities v at time t+ 12∆(t) are calculated ﬁrst and the positions r at time
t+ ∆(t) are calculated from these velocities.
v(t+
1
2
∆(t)) = v(t− 1
2
∆(t)) + a(t)∆t
r(t+ ∆(t)) = r(t) + v(t+
1
2
∆t)∆t
(2.3)
In this way the velocities leap over the positions, then the positions leap over
the velocities.
Periodic Boundary Conditions A molecular system is typically sim-
ulated in a box of some ten thousands of water molecules. The question
arises how to handle the borders of this box. A solution to that problem
is the periodic boundary condition (PBC) [28]. It uses an inﬁnitely tileable
neutrally charged box such that each box interacts on each side with the op-
posite side of its image. Any box shape that tiles space inﬁnitely is possible.
The truncated octahedron has the additional advantage that the number of
water molecules is reduced compared to a cubic box. PBC is typically used
in conjunction with Ewald summation methods such as the particle mesh
Ewald method (PME) [29]. PME separates the pairwise particle-particle-
interactions into a short range and a long range part. The short range part
sums quickly in real space whereas the long range part is treated in its Fourier
transform with the charge density discretized on a grid.
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One single value, typically in the range of 8-12 Å, is set to deﬁne the cut-
oﬀ between short and long range for both van der Waals and electrostatic
interactions. Long-range van der Waals interactions are estimated by a con-
tinuum model. Care has to be taken that the size of the simulation box is
large enough such that the simulated macromolecule does not interact with
its own image in a neighboring box.
2.1.3 Empirical Forceﬁelds
For a mechanical description of a molecular system, a potential energy func-
tion of the atomic coordinates is needed with a deﬁned functional form and
parameters. Because the forces on individual atoms are related to the gra-
dient of this function, the potential function is commonly referred to as
forceﬁeld [30]. Diﬀerent groups of forceﬁelds exist. The most widely used
are Gromos [31], Amber [32], Charmm [33] and OPLS [34]. Forceﬁelds
are parameterized on diﬀerent characteristics, e.g. the Gromos forceﬁeld
is trimmed to accurately model solvation eﬀects while the Amber forceﬁelds
are parameterized against ab initio data.
In this thesis, the two popular Amber forceﬁelds ﬀ99SB [35] and ﬀ03 [36]
have been used for proteins and the generalized Amber forceﬁeld (GAFF)
[37] for ligand molecules. The functional form of the Amber forceﬁeld is
U(r) =
∑
bonds
kb(l − l0)2
+
∑
angles
ka(θ − θ0)2
+
∑
torsions
1
2
Vn[1 + cos(nω − γ)]
+
N∑
i
N−1∑
j>i
{
i,j
[(
r0ij
rij
)12
− 2
(
r0ij
rij
)6]
+
qiqj
4pi0rij
}
(2.4)
As can be seen, the potential contains relatively simple functions describing
the diﬀerent kinds of interatomic forces. The ﬁrst three summations are over
bonds (1-2 interactions), angles (1-3 interactions) and torsions (1-4 interac-
tions) (ﬁgure 2.1). The ﬁrst two are modelled by simple harmonic oscillators
just like usual mechanical ball and spring models. The torsion term can also
include so-called improper torsions where not all 4 interaction partners are
connected via covalent bonds. Torsions are particularly important for cor-
rect protein dynamics and also hard to parameterize. The last summation
models pairwise non-bonded interactions by a 6-12-Lennard-Jones potential
8
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Figure 2.1: Schematic view of
forceﬁeld interactions. Scheme
taken from Ponder et al. [30]. Heavy
solid lines indicate covalent bonds, the
light dashed line indicates nonbonded
interactions.
depending on atomic radii and distances and an electrostatic Coulomb po-
tential depending on partial atomic charges and distances. It iterates over all
pairs of atoms that are separated by more than three covalent bonds and has
usually special parameters for 1-4 interactions. The Lennard-Jones potential
has a dispersion and a exchange repulsion component and is often called the
van der Waals term.
The parameterization of a forceﬁeld is a complex task and will not be dis-
cussed here at length. In the Amber 99 forceﬁeld, van der Waals terms were
adapted from ﬁts to amide crystal data and liquid-state simulations. Force
constants and equilibrium bond lengths and angles are taken from crystal
structures and adapted to match normal mode frequencies for a number of
peptide fragments. Generally, one goal of the parameterization is to obtain
a balanced interaction between solute-water and water-water energies. In-
terestingly, ﬁtting charges to the potentials at the HF/6-31G* level tends to
overestimate bond-dipoles by amounts comparable to that in empirical water
models such as SPC/E or TIP3P. Hence, ﬁtting charges at the HF/6-31G*
level tends to yield charges that are roughly consistent with these water
models [30]. Charges for the Amber forceﬁelds are derived by ﬁtting atom-
centered point charges to a quantum-chemically calculated electrostatic po-
tential on the Connolly surface. This procedure has also been used for the
calculation of sulpho-tyrosine partial atomic charges in subsection 4.1.
Both, the Amber ﬀ99SB and ﬀ03 forceﬁeld, have recently been benchmarked
and found to be particularly well performing in reproducing experimental
residual dipolar couplings [38]. Other NMR observables and conformational
populations of dipeptides available from vibrational spectroscopy have also
been used for benchmarking [39]. Generally, the performance of ﬁxed charge
force ﬁelds is inherently limited, and polarizable forceﬁelds such as Amoeba
[40] are promising but not widely used yet.
2.1.4 Explicit Water Models
Hydration water at biomolecular surfaces plays a key role in protein-ligand
interactions and enzymatic function [41]. At present, the most commonly
used explicit solvent models treat the individual water molecules as rigid
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bodies. The simplest models involve three interaction sites according to the
positions of the oxygen atom and the two hydrogen atoms (ﬁgure 2.2).
Figure 2.2: Geometries of 3-point (left) and 4-point (right) explicit
water models. The interaction site in the 4-point model that lies on the
bisector of the H-O-H angle is usually called the M-site.
They have a negative charge q on oxygen and positive charges −q/2 on the
hydrogens. In the ﬁrst transferable intermolecular potential (TIP) model,
TIPS3 [42], the dimerization energy for two water moleculesm and n is mod-
elled as the sum of intermolecular charge-charge interactions and a Lennard-
Jones term between the oxygens [43] as given in equation 2.5.
Emn =
onm∑
i
onn∑
j
qiqj
rij
+
A
r12OO
− C
r6OO
(2.5)
The parameters (table 2.1) were optimized to give reasonable structural and
energetic results for gas phase complexes of water and liquid water. Berend-
sen reparameterized the same model more thoroughly for liquid water yield-
ing the single point charge model (SPC) [44]. The extended SPC model
(SPCE) adds an average polarization correction to the potential energy func-
tion [45].
q r(OH) r(OM) α(HOH) A C
SPC [44] -0.8200 1.0 - 109.47 2.6171e-3 2.6331e-6
SPCE [45] -0.8476 1.0 - 109.47 2.6171e-3 2.6331e-6
Tip3P [43] -0.8340 0.9572 - 104.52 2.4889e-3 2.4352e-6
Tip4P [42] -1.0400 0.9572 0.15 104.52 2.5543e-3 2.5145e-6
Tip4P-Ew [46] -1.0484 0.9572 0.125 104.52 2.7361e-3 2.7470e-6
Table 2.1: Geometry and potential function parameters for some
important water models. The table lists the respective oxygen charge
q, the lengths of O-H bonds r(OH), the displacement length of the M-site
r(OM), the H-O-H angle α and Lennard-Jones constants A (kJ A˚ 12mol−1)
and C (kJ A˚ 6mol−1).
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Generally, all parameters (charges, OH-distances and Lennard-Jones con-
stants) are optimized to reproduce several diﬀerent types of experimental
data, e.g. density, radial distribution functions, the enthalpy of vaporisation,
heat capacity, diﬀusion coeﬃcient and dielectric constant. However, it is not
possible to satisfy all empirical restraints with one parameter set. For ex-
ample, with the 3-point models, it is not possible to optimize the computed
density without loosing the second peak in the O-O radial distribution func-
tion (not shown). Thus, 4-point models with an additional interaction site
have been introduced, e.g. TIP4P [43]. In this model, the negative charge
is moved oﬀ the oxygen towards the hydrogens at a point on the bisector of
the HOH angle that is usually called the M-site (ﬁgure 2.2). The TIP4P-Ew
is reparameterized to perform better in periodic boundary simulations [46].
There are also more complicated models, e.g. models incorporating 5 or 6
interaction sites, ﬂexible water models including bond stretching and angle
bending conformational changes of the single water molecules and polariz-
able water models. These are of course computationally more expensive than
the simpler ones and are not yet widely used.
The performance of explicit water models has been assessed in several papers
[47, 41]. According to van der Spoel et al. [47], SPCE seems to be the perfect
model for bulk water simulations. But the authors add that they have made
experience were SPCE gave dubious results in protein simulations. Thus,
for the latter, they would prefer SPC. Vega et al. [48] show that from the
simple water models (SPC, SPCE, TIP3P, TIP4P and TIP5P) only TIP4P
provides a qualitatively correct phase diagram of water. A study of hydration
thermodynamic properties [41] comes to the conclusion that for nearly all
hydration properties considered, SPCE water performs best. Any of the
models is parameterized against something speciﬁc and has therefore also
its speciﬁc weakness. For example, SPC and TIP3P water models tend to
underestimate the extent of water structuring close to hydrophobic groups,
while the TIP4P-Ew model tends to yield overstructured hydration shells
with too low enthalpies and entropies and too high heat capacities.
The most widely applied water models are the SPC/SPCE models and
TIP3P in the Gromacs and Amber MD communities, respectively. Because
the Amber forceﬁelds are parameterized against TIP3P [49] and it is the
most eﬃcient among the TIP models, TIP3P is the default model in the
Amber 11 software package. TIP3P water has been used throughout the
present study.
Most recently, rigid body water potentials have been evaluated on their rel-
evance for general purpose [50]. In this extensive test, the models have been
inspected on their ability to reproduce a set of 17 phenomenological water
properties. Although no model reproduces all properties, some models, in
particular TIP4P/2005 [48] and SPCE perform better than the others. How-
ever, there is at present no evidence showing one water model to be clearly
superior for simulations of proteins in water.
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2.2 Continuum Solvation
Because usually approximately 80% of the molecules in a simulation box
are water molecules for which all the interactions have to be calculated in
each integration step, it is desirable to have an approximate model that
is able to suﬃciently represent the properties of water. Furthermore, the
calculation of thermodynamic averages from explicit water models is limited
by the need of integrating over the many solvent degrees of freedom. Because
explicit solvent cannot be sampled suﬃciently, the polar contribution to the
solvation free energy is often calculated with continuum models. Continuum
solvation models approximate the behavior of individual water molecules
by representing the solvent as a dielectric continuum instead of individual
(water and ion) molecules.
Solvation Energy A biomolecule's interaction with the solvent environ-
ment is a major determinant of its structure, dynamics and energetics. Con-
sequently, solvation plays a crucial role in the energetics of ligand binding.
Figure 2.3: Thermodynamic cycle showing the breakdown of the
solvation energy into electrostatic and nonpolar contributions. Fig-
ure is adapted from Sitkoﬀ et al. [51].
Solvation free energy is the free energy diﬀerence of a molecule being in
vacuum or in water. The process of bringing a biomolecule from vacuum
into water can be envisioned as a three-step process (ﬁgure 2.3) [51]:
1. Discharging the solute in vacuo
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2. Transferring the, now considered totally nonpolar, solute into water
3. Recharging the solute in water
Thus, the solvation energy can be evaluated as a sum of these single energies.
The polar parts are usually treated together.
Gsol = Gpol,vac +Gnp +Gpol,wat = Gpol +Gnp (2.6)
2.2.1 Poisson-Boltzmann
The Poisson Boltzmann model (PB) is based on the Poisson equation that
allows to calculate the electrostatic potential directly from the molecular
charge density in a homogeneous medium
∇ [(r)∇φ(r)] = −4piρ(r) (2.7)
where φ(r) is the electrostatic potential, ρ(r) is the charge density and (r)
the permittivity. To account also for the impact of point charges (ions) in
nonhomogeneous media, the Boltzmann part has to be introduced to yield
the Poisson-Boltzmann equation
∇ [(r)∇φ(r)] = −4piρf (r)− 4pi
∑
i
c∞i ziqλ(r)e
−ziqφ(r)
kT (2.8)
where ρf (r) includes now only molecular charges, ci is the concentration of
ion i at an inﬁnite distance from the molecule, zi is its valency, q is the
proton charge, k is the Boltzmann constant, T is the temperature and λ(~r)
describes the accessibility to ions at point ~r [52]. (r) is discontinuous along
the biomolecular surface and assumes solute dielectric values inside and bulk
solvent values outside the surface (ﬁgure 2.4). The biomolecular surface is
deﬁned as the solvent excluded surface using Bondi radii [53].
Figure 2.4: Deﬁnition of the dielectric boundary.
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It is not straightforward to set the protein dielectric constant. An internal
protein dielectric of 1 can be used. This means that there is no account for
atomic polarizability. 2 would be a reasonable choice because the refraction
index of most biomolecules is roughly 1.4 and the dielectric constant is the
square of the refraction index. There is also experimental justiﬁcation to use
a dielectric of 4 [54].
When the Poisson equation began to become relevant for the electrostat-
ics of biomolecules, the latter where ﬁrst approximated as bodies of regular
shapes with equal surface area, e.g. spheres. Numerical solutions for the
Poisson-Boltzmann equation have made it possible to solve the Poisson-
Boltzmann equation for arbitrary shapes. Diﬀerent variants of the ﬁnite
diﬀerence method are used for that. Generally, the molecular charges and
dielectric are discretized on a grid [52]. To eventually evaluate the polar
solvation energy of a molecule, the reaction ﬁeld has to be calculated from
electrostatic potentials both in solvent ( = 80) and in vacuum ( = 1) [52].
In the grid-based approach, this simpliﬁes to a discrete formula.
Gpol =
1
2
∫
V
ρ(r)φreac(r)dV =
1
2
∑
i
qi(φsol(ri)− φvac(ri)) (2.9)
These calculations are computationally demanding both in CPU time and
memory [54].
2.2.2 Generalized Born
The generalized Born model (GB) has become popular for MD applications
because of its relative simplicity and computational eﬃciency [55]. The
model is based on the formula of Max Born for the solvation energy of single
ions [56]
∆GBorn = − q
2
2a
(1− 1
w
) (2.10)
where q is the ion charge, a the radius and w the solvent dielectric constant.
Generalizing the Born model, a molecule is modelled consisting of charges
q1...qN embedded in spheres of radii a1...aN , and the polar solvation free en-
ergy can be given by a sum of individual Born terms and pairwise Coulombic
terms [57]:
∆Gpol =
N∑
i
q2i
2ai
(
1
w
− 1) + 1
2
N∑
i
N∑
j 6=i
qiqj
rij
(
1
w
− 1) (2.11)
GB theory tries to resemble equation 2.11 by parameterizing an eﬀective
14
2.2 Continuum Solvation
function fGB. The polar solvation energy then reads
∆Gpol = −1
2
(
1
w
− 1)
∑
ij
qiqj
fGB(rij , Ri, Rj)
(2.12)
with fGB being most often of the form
fGB(rij) = [r
2
ij +RiRjexp(−r2ij/4RiRj)]
1
2 (2.13)
where R are the so-called eﬀective Born radii. These reﬂect the degree
of burial of an atom inside the molecule. As they depend on the protein
conformation, they must in principle be reevaluated at any time step in a
MD simulation.
Diﬀerent approaches to the calculation of the eﬀective functions and radii
exist. Several of them are implemented in the Amber software package,
namely GBHCT [58], the original Hawkins, Cramer, Truhlar approach with
parameters by Tsui and Case, GBOBC I and II [59], an improvement from
Onufriev et al. with two diﬀerent parameterizations intended to be a closer
approximation to the true molecular volume and GBn [60], a model pro-
posed by Mongan et al. introducing a more robust volume correction.
Although GB is an approximation to PB, it has been experienced that it per-
forms slightly better on calculating solvation free energies on small drug-like
molecules [61]. This is possible if the numerical inaccuracy in the solution of
the PB model is larger than the approximation introduced by the assump-
tions of the GB model. For that reason, GB is not exclusively interesting for
eﬃciency reasons and has therefore been included in the MMPBSA study in
this thesis work.
2.2.3 Nonpolar Solvation
The nonpolar contribution to the solvation energy is composed of the cost
of creating a cavity within the solvent to accomodate the solute together
with nonpolar interactions (dispersion and exchange-repulsion) between the
solute and solvent molecules.
Hermann et al. [62] found out, that the number of water molecules that can
be packed around a solute molecule correlates well with the transfer energy
of nonpolar molecules into water. A slightly more idealized measure is the
cavity surface which contains the centers of the water molecules in the ﬁrst
layer around the solute. The logarithm of the transfer energy of alkanes into
water correlates linearly with the alkanes surface areas [62]. Based on this
ﬁnding, a model has been developed [51]
Gnp = γSASA+ b (2.14)
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where γ and b are empirical parameters ﬁtted to experimental solvation
energies. For the calculation of the SASA, a new empirical atomic radii
set, the parameters for solvation energy (PARSE) [51], has speciﬁcally been
developed.
Other, more advanced approaches exist, namely the cavity-dispersion method
(CD) [63] and the polarizable continuum model (PCM) [64, 65]. These have
not been used within this study and are therefore not explained. The accura-
cies of nonpolar solvation methods have recently been investigated, revealing
substantial qualitative diﬀerences between the diﬀerent models [66].
Solvent-Accessible Surface Area (SASA) A molecule is deﬁned as set
of atoms with radii Ri and positions ri(x, y, z) (ﬁgure 2.5).
Figure 2.5: Deﬁnition of the solvent-accessible surface area.
The molecular surface is scanned by a probe sphere of a radius corresponding
to a solvent molecule (1.4 Å for water). The surface deﬁned by the center of
the sphere is the solvent-accessible surface.
A general problem with implicit solvent models in the context of calculat-
ing protein-ligand binding aﬃnities is that these models assume the ligand
binding cavity to be ﬁlled with water in the free state. This may be sim-
ply incorrect for very small cavities or at least a very crude approximation
because the hydration structure might be of particular importance [67].
2.3 Sampling
Physical macroscopic properties such as the free energy of binding cannot
be accurately calculated from a single structure alone. Theoretically, a rep-
resentative Boltzmann-averaged statistical ensemble is needed. However,
conventional MD simulations in the canonical ensemble tend to get trapped
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in local minima that are separated by high energy barriers which are rarely
passed. Using conventional MD, the conformational space of a solvated pro-
tein system cannot suﬃciently be explored in a practical amount of time.
Thus, more advanced techniques have to be applied to overcome this prob-
lem. Many diﬀerent approaches have been devised. One crucial criterion
that diﬀerentiates these methods is if the Hamiltonian is changed during
simulation or not. Most of these strategies such as REMD are mainly in-
teresting to sample long time scale motions and are thus not particularly
suited to enhance sampling for e.g. MMPBSA calculations. In the following,
I will explain the thermodynamic ensembles together with the corresponding
algorithms to obtain these ensembles and give a short overview on a subset
of interesting MD-based sampling algorithms.
2.3.1 Thermodynamic Ensembles
NVT In the canonical ensemble (NVT), the number of particles, the vol-
ume and the temperature are constant. The temperature, that is deﬁned by
the ensemble average of kinetic energies, is kept constant by a thermostat
that exchanges energy with the environment. Several approaches exist to
perform the temperature control, mainly the Berendsen [68], Langevin [69]
and Nosé-Hoover [70, 71] thermostats. The Berendsen thermostat, also called
coupling to an external heat bath, controls the temperature by rescaling
the particle velocities by a constant factor. Nosé-Hoover is an integral type
of thermostat. It introduces the heat bath in terms of additional degrees of
freedom into the Hamiltonian of a system. The Langevin thermostat, that
has been used throughout this thesis, regulates the temperature by adding
random frictional forces from a Gaussian distribution to adjust the kinetic
energy of the particles. The collision frequency controls the magnitude of
these forces. Simulations performed with a higher collision frequency (5 ps−1
compared to 1 ps−1) have small but noticeable higher relative RMSD (com-
pared to the starting structure) than simulations performed with a lower
collision frequency.
NPT The isothermic-isobaric ensemble (NPT) corresponds more to lab-
oratory conditions, i.e. ambient (constant) temperature and pressure. The
natural environment is able to compensate the volume change of a molec-
ular system. Therefore, in addition to a thermostat, a barostat is needed.
The pressure control is usually accomplished by extending and shrinking the
simulation box volume by isotropic position scaling (Berendsen barostat).
2.3.2 Multiple Independent Simulations
One way to enhance sampling is to do multiple simulations using varying
initial conditions. A number of quite arbitrary choices has to be made when
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setting up MD simulations. The eﬀects of some of these choices on the
sampling diversity has been investigated by Genheden et al. [72]. From
these considerations, three important possibilites to enhance sampling by
using multiple simulations can be suggested:
1. VIIT - velocity induced independent trajectories
2. CIIT - conformation induced independent trajectories
3. SIIT - solvent induced independent trajectories
In VIIT, diﬀerent initial random velocities are used, CIIT uses diﬀerent ini-
tial conformations if these are available from given crystal structures, and
SIIT uses diﬀerent initial waterbox conﬁgurations. Combinations of these
approaches have been used for the MMPBSA calculations and MD studies
in this thesis. A justiﬁed criticism to this approach is that short simula-
tions will not sample energy minima that are further away from the starting
conformation on the potential energy landscape. These more distant energy
minima are more probable to be reached by one long simulation. However,
simulations with diﬀerent initial conditions tend to propagate into diﬀerent
directions overcoming some energy barriers right in the beginning of the sim-
ulations. This is evident from the fact, that calculated MMPBSA energies
from multiple simulations converge to distinct values in a broad range and
they do not converge to one same value in an appropriate amount of simula-
tion time. Consequently, the total amount of energy barriers crossed could
be larger with the multiple short simulation setup. This is an interesting
question that could be tested computationally.
2.3.3 Rotatable Dihedral Accelerated Molecular Dynamics
In accelerated molecular dynamics (aMD) [73], a bias potential is added
to the original potential such that the potential energy wells are elevated
whereas the transition state regions remain unaltered. It has been shown
that a correct canonical distribution can be extracted by applying a reweigh-
ing scheme. The method has recently been shown to dramatically improve
sampling providing routine access to millisecond events [74]. In the more re-
cently presented RaMD approach [75], only the rotatable dihedrals that are
most responsible for conformational changes of biomolecules are subjected
to aMD yielding an accuracy comparable to aMD while greatly improving
the eﬃciency.
2.3.4 Replica Exchange Molecular Dynamics
In the replica exchange method (REMD) [76], also called parallel temper-
ing, a number of MD simulations (replicas) are started at diﬀerent tempera-
tures. Based on a decision made by a Metropolis criterion, the temperatures
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between trajectories are exchanged at certain times. Exchanging confor-
mations between high and low temperature replicas avoids the trapping in
low energy conformations which is the typical problem of conventional MD.
The pairs of trajectories that are exchanged need to have signiﬁcantly over-
lapping energy distributions. REMD is particularly suited to investigate
slow dynamic phenomena such as protein folding. It is on the other hand
probably not suited for free energy calculations such as MMPBSA since we
there want to sample locally around an equilibrium state. It is furthermore
not straightforward to obtain a Boltzmann ensemble from REMD [77]. It
has also been stated, that REMD has so far not shown to be eﬃcient and
has further theoretical problems, e.g. the entropic part of the temperature
dependent transition rate is unaltered by increasing the temperature [78].
2.3.5 Free Energy Guided Sampling
Another promising approach is the free energy guided sampling algorithm
(FEGS) developed by Zhou et al. [78]. FEGS explores conformational space
using unbiased MD simulations, e.g. no collective variables or reaction coordi-
nates are needed. In a ﬁrst exploration stage, multiple short simulations are
iteratively restarted from regions of the free energy surface that are visited
rarely, thus increasing the probability for passing high energy barriers. In a
second reﬁnement stage, multiple independent runs are initiated from Boltz-
mann distributed conformations to yield an overall Boltzmann distributed
ensemble. A mean ﬁrst passage time cutoﬀ can be used to control the kinetic
range of sampling.
2.3.6 Performance Gains from Hardware
Developers of several MD software packages, in particular OpenMM and
Amber, are trying to use the power of graphic processing units (GPU) to
accelerate MD simulations. In April 2011, Amber 11 was released [79] with
a GPU version of pmemd, the Amber MD routine. It uses CUDA and runs
exclusively on NVIDIA cards. I have tested the implementation ﬁrst on
GTX295 and then on Tesla c1070 cards at the informatics department of the
university at Münster and observed remarkable speedups (ﬁgure 2.6).
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Figure 2.6: Performance gains using GPUs. Y-axis shows computer
run time needed to simulate 20 ps of each system shown on the x-axis with
an 8-CPU compute node (connected dots), a GTX295 GPU (bars) and a
Tesla c1070 GPU (dots).
In August 2011, a new pmemd GPU version was released with a major code
change (bugﬁx 17) with again substantial performance improvements and the
2012 version has support for some newer graphic cards [80]. At present, for
typical production MD simulations, one compute node with two Tesla M2050
easily outperforms ten 8-CPU compute nodes (Xeon E5440 2.83GHz) while
these components have roughly the same price of approximately 6500¿. This
is a crucial advance that should be noticed by anyone who is interested to
buy hardware speciﬁcally for MD simulations (ambermd.org/gpus).
2.4 Conformational Entropy
To calculate the binding aﬃnity by MMPBSA (equation 3.14), the conforma-
tional entropy has to be evaluated. The conformational entropy of a protein
is the sum of translational, rotational and vibrational entropies.
Sconf = Strans + Srot + Svib (2.15)
While the ﬁrst two terms are simply calculated with statistical mechanics
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formulas alone [81], the latter needs vibrational frequencies ν as an input:
Svib = R
3N−6∑
i=1
(
hνi
kBT
1
ehνi/kBT − 1 ln(1− e
hνi/kBT )) (2.16)
where νi are the vibrational frequencies vi, h and k are Planck and Boltz-
mann constants, respectively and T the absolute temperature. Within the
MMPBSA framework, these frequencies are commonly calculated from nor-
mal modes.
2.4.1 Normal Model Analysis
The normal modes of a molecule are obtained as follows:
The Hessian matrixH contains the second partial derivatives of the potential
energy function (equation 2.4). For a system of N atoms, it is a 3N × 3N
matrix.
H(r) =
[
∂2V (r)
∂ri∂rj
]
=

∂2V (r)
∂x1 ∂x1
∂2V (r)
∂x1 ∂y1
· · · ∂
2V (r)
∂x1 ∂zn
∂2V (r)
∂y1 ∂x1
∂2V (r)
∂y1 ∂y1
· · · ∂
2V (r)
∂y1 ∂zn
...
...
. . .
...
∂2V (r)
∂zn ∂x1
∂2V (r)
∂zn ∂y1
· · · ∂
2V (r)
∂zn ∂zn

(2.17)
The normal modes are eigenvectors of the Hessian matrix. The eigenvectors
together with their corresponding eigenvalues are obtained by diagonaliza-
tion of the Hessian. Each normal mode is then treated as an harmonic oscil-
lator, thus, the frequencies of the harmonic normal modes (entering equation
2.16) can be expressed as
νi =
1
2pi
√
λi
µ
(2.18)
where λi are normal mode force constants and µ is the reduced molecular
mass.
To put it more descriptive, NMA estimates the conformational entropy by
measuring the widths of the potential energy wells of each MD snapshot.
To do so, it assumes these wells to be harmonic as an approximation. To
make the harmonic assumption valid, the molecule conformation must be
minimized as close as possible to the true minimum of the nearest potential
well [82, 83]. Otherwise, substantial error can occur. To this end, prior to
the frequency calculation, a second-derivative based minimization approach
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(Newton-Raphson) is usually applied. Both, geometric optimization and
NMA are time-consuming and computer-memory demanding tasks.
2.4.2 Alternatives
The frequencies for the calculation of the vibrational entropy can in principle
be taken from diﬀerent sources, e.g. from principal components from the
covariance matrix of the MD simulation. This approach is called quasi-
harmonic analysis (QHA) [84]. Another approach is the Schlitter entropy
that turned out to be an approximation which yields the result of the QHA
in its upper limit [85, 86]. Another recent approximate and fast approach is
to calculate the entropy directly from the SASA [87].
2.5 Trajectory Analysis
2.5.1 Root Mean Square Deviation
A rough indicator for the stability of MD simulations is the root mean
squared deviation (RMSD)
RMSDj =
√√√√ 1
N
N∑
i
(xj,i − xR,i)2 (2.19)
where N is the number of atoms and x are atomic coordinates. The RMSD
that is typically reported in this context is the minimized RMSD between
each trajectory frame j and a reference structure R, most commonly the
initial structure. The alignment algorithm by Kabsch and Sander [88] (to-
gether with an additional translation step) is used to perfectly align a set
of chosen atoms by translation and rotation to minimize the RMSD. The
selected group of atoms for the alignment may vary. Commonly used are
Cα atoms only, backbone atoms only or all atoms. Practically, the resulting
RMSD diﬀerences among these variants are however marginal.
2.5.2 Root Mean Square Fluctuation
The root-mean square ﬂuctuation (RMSF) is a measure for thermal motion.
It is analogous to and often correlates well with experimental b-factors. It
is based on the atom coordinates deviations from their time-average. There-
fore, aligning all frames to the average structure is required prior to the
RMSF calculation. Residue ﬂuctuations can be based on the Cα atom coor-
dinates or the positions of the residues center of mass. The RMSF for each
residue i is given by
RMSFi =
√√√√ 1
T
T∑
j
(xi(tj)− x¯i)2 (2.20)
22
2.5 Trajectory Analysis
where x are positional coordinates and T the number of simulation frames.
2.5.3 Distance and RMSF Analysis using SAM
To detect signiﬁcant structural diﬀerences induced by point mutations, it
is straightforward to analyze certain features such as e.g. average distances.
Angles and dihedrals could also be taken into account but these can be ex-
pected to give redundant information. Additionally, changes in ﬂexibility
can be tracked by analyzing either the variances of distances or residue root
mean square ﬂuctuations. The most naive approach to detect signiﬁcant
diﬀerences of such features is an ordinary student's t-test on each individual
feature. This is however problematic when testing a very large number of
features. If one intends to test for example for diﬀerences of 100 features at
a signiﬁcance level of 0.05, then ﬁve false positives are expected even if there
are no signiﬁcant diﬀerences. This is a common problem of multiple testing.
One typical means to handle this problem is the Bonferroni correction that
corrects the signiﬁcance level to adapt it to a large number of features. This
method however still simply assumes the features to be independent from
each other and it is more suited for a relatively small number of features
(around 20) [89]. One of the most advanced statistical tools to handle the
multiple testing problem is, besides the global rank test [90], the signiﬁcance
analysis of microarrays (SAM). The method has been developed to detect
signiﬁcant genes from microarray expression experiments where a large num-
ber of false positives cannot be tolerated. It was ﬁrst applied to microarray
data from investigations on the ionizing radiation response by Tusher et al.
[91]. There it was compared to the Bonferroni correction (and one of its
adaptations allowing for dependent tests by Westfall and Young [92]) and
shown to give more useful results in this test case.
Signiﬁcance Analysis of Microarrays (SAM) SAM has been imple-
mented by Schwender in the R package siggenes [89, 93]. The procedure is
described there and it goes as follows:
The input data is an m × n matrix comprising the expression values of m
genes and n observations with a corresponding response (or class) vector of
length n. B is the number of permutations to estimate the null distribution.
 For each gene i, i = 1, ...,m, the value di of a statistic appropriate for
testing (moderated t-test or Wilcox) is computed.
 The null distribution d0(i) is estimated by computing the m permuted
d-statistics dib for each permutation b, b = 1, ..., B of the n values of
the response, and d0(i) is set to
∑B
b=1 d(i)b/B. The determination of a
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correct theoretical null distribution is crucial for the determination of
the FDR.
 For a set D of discrete positive tresholds ∆, an upper and a lower
cutoﬀ is determined. These cutoﬀs deﬁne a set of genes S∆ called
diﬀerentially expressed.
 As an error estimate, the false discovery rate (FDR) for each S∆ is
determined.
Figure 2.7 shows a typical SAM output.
Figure 2.7: SAM example plot showing the expected versus observed d(i)
values from the moderated t-statistic. Horizontal lines show the chosen cut-
oﬀs that deﬁne the set of genes called diﬀerentially expressed (green).
The described approach has been used for the identiﬁcation of signiﬁcant
distance and RMSF diﬀerences induced by point mutations of the HCV pro-
tease. How the method was used on this data is more speciﬁcally described
in subsection 4.4.
2.5.4 Concerted Motions from a Distance Covariance
In a recent work, the potential of a distance correlation coeﬃcient (DiCC) to
detect long-range correlated ﬂuctuations has been investigated [94]. DiCC
was compared to other variants of correlation coeﬃcients, namely the dis-
placement vector correlation coeﬃcient (VCC) that is an extension to the
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Pearson correlation coeﬃcient for positional vectors and a generalized cor-
relation coeﬃcient (GCC). It has been shown that long-distance concerted
motion could be observed with DiCC that could not be revealed with the
other correlation coeﬃcients. Likewise, the atom-by-atom correlation matrix
exhibits a more pronounced proﬁle than the matrices from VCC and GCC
(ﬁgure 2.8).
Figure 2.8: Comparison of Correlation Coeﬃcients. Correlation ma-
trices from VCC, GCC and DiCC between Cα atoms of Src SH2 domains.
(Source: Roy et.al. [94])
The algorithm for the calculation of the DiCC is described in Roy et al. [94].
In this thesis, DiCC was used to investigate if a certain point mutation, in
particular the HCV protease mutation I71T, induces changes in such long-
range concerted motions. DiCC diﬀerences were investigated using the SAM
method (subsection 4.4).
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3 Free Energy of Ligand Binding
A drug is a small molecule that exerts its action by binding to a target
protein. This protein is very often an enzyme. Most commonly, as in the case
of the HIV protease, the drug molecule inhibits the enzyme competitively,
which means that it blocks the binding of the physiological substrate to the
active site. If the drug is a tight binder, many of the target proteins will be
occupied at one instant of time at chemical equilibrium. Any small molecule
that binds to a receptor protein is usually termed a ligand but the term is
actually used more broadly for any molecule that binds another one.
3.1 Binding Aﬃnity and Equilibrium
In an aqueous solution with ﬁxed concentrations of protein and ligand at
thermal equilibrium, there is constant complex formation and dissociation.
In the non-covalent case, the complex formation of a ligand L and a protein
P can then be formulated by the following chemical reaction:
P + L
kassociate−−−−−−⇀↽ −
kdissociate
PL (3.1)
where kassociate and kdissociate are the formation and dissociation rates, re-
spectively. The reaction is governed by the binding constant KB given by
the ratio of concentrations of the free and bound species:
KB =
kassociate
kdissociate
=
[PL]
[P ][L]
(3.2)
The Gibbs free energy of binding is related to KB by the equation
∆G = −RT ln(KB) (3.3)
where R is the general gas constant and T the absolute temperature.
3.2 Measurement Methods
Several useful methods exist to determine the binding aﬃnity of a ligand to a
protein experimentally. I will explain here the three most relevant quantities:
the inhibition constant Ki, the inhibitory concentration IC50 and the free
energy of binding calculated from isothermal titration calorimetry, ∆GITC .
Enzyme inhibition assays measure the inhibition constant Ki or the in-
hibitory concentration IC50. For enzyme inhibitors, the dissociation constant
Kd, the reciprocal of the binding constant, is usually termed the inhibition
constant. These assays are convenient on one hand because the enzyme acts
as an ampliﬁer and carries out many reactions that can be measured. On
the other hand, a protein-speciﬁc procedure has to be established to detect
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the release of products [95].
3.2.1 Inhibition Constant Ki
In the most simple setup, theKi can be determined by measuring the fraction
f of free protein (spectroscopically or based on its enzyme activity) as a
function of the concentration of free ligand [95].
f =
[P ]eq
[PL]eq + [P ]eq
=
1
1 +KB[L]eq
(3.4)
3.2.2 Inhibitory Concentration IC50
In the typical clinical setup of resistance testing, drug eﬃciency is measured
phenomenologically. Cell cultures with increasing drug concentrations are
infected with a resistant recombinant virus. For comparison, further cell
cultures are infected with non-resistant (wildtype) virus in the same manner.
The IC50 is the drug concentration that reduces the cell culture activity to
50% of that of the reference culture [96]. One option for the measurement
of cell culture activity are so-called indicator viruses. In the case of HIV,
the nef gen, which is not needed for viability in immortalized T cell lines, is
substituted by an indicator gen (e.g. β-galactosidase or luciferase). During
replication, the viruses produce the corresponding indicator protein instead
of the nef protein. The amount of this protein can be determined by ELISA
or luminometric testing and correlates directly to the number of viruses [96].
The IC50 depends strongly on the cell lines used. It is therefore reasonable to
unite the IC50 values of wildtype and mutant in one parameter, the resistance
factor (RF).
RF =
ICWT50
ICMT50
(3.5)
The resistance factor (RF), that expresses how much more medicament is
needed to decrease the mutant virus growth by 50% relative to the wildtype
is directly related to the relative Gibbs free energy of binding.
∆∆G = ∆GWT −∆GMT ≈ − kT ln(RF ) (3.6)
The measured IC50 is generally expected to be greater thanKi, but formally,
the IC50 is related to the Ki via the Cheng-Prusoﬀ equation [97]
Ki =
IC50
1 + [L]Km
(3.7)
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where [S] is a ﬁxed substrate concentration and Km is the substrate concen-
tration with half-maximal enzyme activity. The equation implies that the
IC50 becomes essentially equal to Ki for very low substrate concentrations.
Corresponding ∆G values are obtained from enzyme assay data via the re-
lations
∆G = −RT lnKi
≈ −RT ln IC50 (3.8)
3.2.3 Isothermal Titration Calorimetry ∆GITC
The most exact method to determine ∆G is isothermal titration calorimetry
(ITC). It is also the most expensive method because much more enzyme is
needed for one measurement. However, the procedure is more generic and
does not require any system speciﬁc adaptations.
A solution with a ﬁxed enzyme concentration is kept at constant temper-
ature by a thermostat. Ligand is then steadily injected and its binding to
the enzyme leads to a temperature change of the solution. The amount of
energy that is needed to keep the temperature constant can be accurately
measured and calculated back to the binding free energy of one ligand and
one enzyme molecule.
A thoroughly managed collection of binding aﬃnities is administrated by
Gilson and coworkers [98] available at www.bindingdb.org. Binding DB cur-
rently contains about 620000 binding data for 5500 proteins and over 270000
drug-like molecules.
Figure 3.1: Distribution of available binding aﬃnity measures from
BindingDB.
The uncertainties of ∆G measures are not always given and they are usually
around 0.4 kcal/mol [99].
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3.3 Employed Free Energy Methods
Biomolecular modelling concepts can be applied to calculate the free energy
of protein-ligand binding. Numerous concepts can be used to calculate free
energies and in the following, I brieﬂy explain the two I have used in this
thesis.
3.3.1 Thermodynamic Integration
The thermodynamic integration method (TI) is a rigorous (theoretically ex-
act) method to calculate relative binding aﬃnities entirely based on sta-
tistical mechanics [100]. In this thesis, the relative free energy of binding
between wildtype HIV protease bound to atazanavir and the mutant L76V
has been calculated (subsection 4.3) and is used here as illustrative example.
Instead of calculating the diﬀerence of absolute binding free energies of two
protein-ligand complex variants, the relative binding aﬃnity is calculated by
estimating the energy diﬀerences of the alchemical transformations of one
variant into the other in the bound and unbound state (ﬁgure 3.2).
Figure 3.2: Thermodynamic cycle illustrating the TI formalism.
The transformations of bound and unbound state can be substituted by
alchemical transformations from wildtype to mutant. The point mutation is
colored red.
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The free energy diﬀerence between two λ-coupled states according to the TI
formalism is
∆GTI =
∫ 1
0
〈δV (λ)
δλ
〉
λ
dλ (3.9)
In this equation V is the λ-coupled potential function corresponding to VL76
for λ=0 and V76V for λ=1. Since this equation can practically not be solved
analytically for such a complex system, an integration scheme is used that
numerically determines the value of the integral from simulations at dis-
crete λ values. This scheme allows for eﬃcient parallelization and also for
additional λ values in regions where convergence has not been suﬃciently
achieved.
A simple way to couple the two end-point potential functions into the mixed
potential V(λ) is
V (λ) = f(λ)V1 + [1− f(λ)]V0 (3.10)
with f(λ) = λ yielding a linear coupling of the potential functions.
The two transformations, L76 to 76V, in the bound and the unbound state
are furthermore split into three transformation steps. In the ﬁrst step,
charges on L76 are turned oﬀ, in the second step, van der Waals param-
eters are transformed and in a third step, 76V charges are turned on. The
details of the implementation are given in subsection 4.3.
3.3.2 MMPBSA
A popular method to calculate the free energy of protein ligand binding is the
molecular mechanics Poisson-Boltzmann surface area method (MMPBSA)
pioneered by Massova and Kollman [101, 102, 103]. It combines molecular
mechanics with continuum solvation models and an estimate for the free
energy diﬀerence that results from a change in the conﬁgurational entropy.
Molecular dynamics simulation is used to sample the conﬁgurational space
of the protein ligand complex and the energy estimate is calculated as an
average over an equally spaced subset of snapshots. In terms of its theo-
retical framework, MMPBSA is designed to calculate absolute binding free
energies. However, since the calculated energies strongly depend on the sol-
vation model that is used, only relative energies can be considered useful.
In contrast to alchemical free energy calculations, MMPBSA is a so-called
end-point method meaning that no intermediate states have to be taken into
account reducing the states that have to be simulated to the bound and
the unbound state. For that reason, MMPBSA is thought to be more ef-
ﬁcient than alchemical calculations. Furthermore, the use of MMPBSA is
not limited to the calculation of free energy diﬀerences of structurally sim-
ilar systems. The basic idea can be illustrated by a thermodynamic cycle
(ﬁgure 3.3).
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Figure 3.3: Thermodynamic cycle for the calculation of the binding free
energy of a protein P and a ligand L forming a complex C in solution, ∆Gsb.
Molecules in the blue box are considered solvated. ∆Ggb is the binding free
energy in the gas phase, ∆GPsol, ∆G
L
sol and ∆G
C
sol the solvation energies of
the protein, ligand and complex, respectively.
Given that the energy diﬀerences between states in a thermodynamic cycle
by deﬁnition sum up to zero, the absolute Gibbs free energy of binding in
solution ∆Gsb can be calculated as a sum of the gas phase binding energy
∆Ggb and the diﬀerence of solvation energies of the bound (C) and free (P ,L)
species:
∆Gsb = ∆G
g
b + ∆G
C
sol − (∆GPsol + ∆GLsol) (3.11)
The gas phase binding energy is calculated as the sum of ensemble averages of
molecular mechanics energies minus the conﬁgurational entropy Sconf mul-
tiplied by the absolute temperature T :
Ggb = 〈Eint〉+ 〈Evdw〉+ 〈Eele〉 − T 〈Sconf 〉 (3.12)
where Eint are the internal energies (bond stretching, angle bending and
dihedral torsion), and Evdw and Eele the van der Waals and electrostatics
non-bonded energies, respectively. Angular brackets denote ensemble aver-
ages over snapshots from molecular dynamics trajectories. The solvation
energy is subdivided in an electrostatic and a non-electrostatic part, Gpol
and Gnp.
Gsol = 〈Gpol〉+ 〈Gnp〉 (3.13)
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In summary, we can write:
∆Gsb = 〈∆Eint + ∆Evdw + ∆Eele − T∆Sconf + ∆Gpol + ∆Gnp〉 (3.14)
The energy contributions are derived separately for each molecular dynamics
snapshot. ∆Evdw and ∆Eele can be read directly from the already calcu-
lated potential energy function of the MD simulations that has been con-
ducted to produce the snapshots. Theoretically, bound and unbound states
would have to be simulated separately to account for conformational rear-
rangements that occur upon binding - the induced ﬁt eﬀect. This approach
however practically brings about inaccuracies due to sampling issues which
are typically much larger than the approximation of neglecting the induced
ﬁt eﬀect. It is therefore common practice in MMPBSA calculations to only
simulate the complex in solution and take the receptor and ligand coordi-
nates from the complex. This is in turn slightly more eﬃcient. This practice
is referred to as the single-trajectory-approach. It leads to cancellation of
∆Eint. ∆Gpol is usually calculated with an implicit solvation model, either
Poisson-Boltzmann (2.2.1) or Generalized Born (2.2.2). The performance of
other approaches such as e.g. the reference interaction site model (RISM)
have also been investigated [104]. ∆Gnp is calculated as a linear correlate to
the SASA (2.2.3). Especially this term has been shown to be very approx-
imate leading to severe inaccuracies [66, 67]. The theoretical foundation of
this thermodynamic cycle has also been criticized [105, 106].
Over the last 10 years, the MMPBSA method has been extensively tested
and used to elucidate details of protein-protein [22, 107] and protein-ligand
interactions. The experiences made with the use of MMPBSA are diverse
ranging from encouraging to unsatisfactory results. A pretty good corre-
lation to experimental results has been obtained for a congeneric series of
ligands to FKBP12 [108]. However, it is worth noting that FKBP12 is a
relatively small and rigid receptor and the system might not be representa-
tive for a general benchmark. Furthermore, ranking of congeneric series is
typically less diﬃcult than ranking aﬃnities of diﬀerent protein variants to
the same inhibitor, probably because the conformational space of the ligand
is smaller than that of the receptor. Especially HIV protease inhibitor com-
plexes have been extensively studied typically yielding good agreement with
experimental values [109, 23, 24, 110]. Wittayanarakul et al. have stated
that the identiﬁcation of the correct protonation state of the HIV proteases
catalytic aspartats for speciﬁc drugs is a prerequisite for the correct ranking
of inhibitor aﬃnities. While this is certainly true by itself, the outcome of
this study is probably more governed by limited sampling [110]. An out-
standingly accurate result has been obtained for HIV protease saquinavir
complexes [111]. However, in a more recent paper, the authors state that
this result was only possible by choosing the right ... sampling trajecto-
ries [112]. An appealing feature of the MMPBSA method is the energy
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residue decomposition, i.e. the possibility to i) break down the binding ener-
gies into their separate van der Waals and electrostatic contributions and ii)
partition these energy contributions on a per residue basis. This procedure
gives information that is not amenable to non-computer experiments and it
can give valuable hints and directions for the speciﬁc development of new
drugs that are stronger binders and more robust against the emergence of
resistance mutations [113, 24, 25, 114]. The experiences with MMPBSA are
also often controversial. While Jenwith et al. experience that incorporating
protein ﬂexibility through the use of MD simulations improves correlation
with experimental aﬃnities [115], Rastelli et al. ﬁnd, in an assessment for
virtual screening, that using only one snapshot is often better than using MD
[116]. Pearlman et al. experienced the three-trajectory approach to be su-
perior over the single-trajectory-approach and MMPBSA to perform poorly
compared to commonly used scoring functions [117]. Some special uses of
MMPBSA include the investigation of the role of interface waters in binding
[118], or the identiﬁcation of conformational substates [119]. An extensive
systematic study has been performed by Ryde and coworkers in a series of
papers [120, 72, 121, 61, 66, 67, 122]. Most importantly, it has been convinc-
ingly shown that using an ensemble of many short simulations instead of one
long simulation improves the convergence of binding free energy estimates
and is necessary to get reproducible results [120]. Independent simulations
can be obtained in several ways, e.g. using diﬀerent initial atom velocities or
diﬀerent initial coordinates for the water molecules of the solvent box [72].
Considering the severe sampling issues, all MMPBSA studies using only one
simulation per system have to be interpreted with caution. Only few studies
exist using multiple trajectories to reach better convergence [120, 112, 123].
Besides the sampling issue the inaccuracy of the non-polar term [66, 67] and
the convergence diﬃculties of the NMA entropy estimate are most crucial.
In fact, it was often observed that neglecting the conformational entropy
term gives results closer to experimental aﬃnities (e.g. [112]). Given its in-
trinsic imprecision, MMPBSA has lost its greatest appeal, - that of being
more eﬃcient than rigorous methods.
From the literature study, it became apparent that MMPBSA can possibly
be improved by the following means:
Multiple Independent Simulations. With improved simulation algo-
rithms and especially the GPU code (2.3.6), more sampling is possible. Sim-
ulation times of above cited studies typically range from few hundred pi-
coseconds to 10 ns. A set of multiple simulations is believed to improve the
convergence of MMPBSA free energy estimates.
Truncation Approach with Fixed Buﬀer Region. To reduce compu-
tational complexity of the normal mode entropy calculation, one approach
that has been introduced and often used, is, to truncate all residues that
are farther away from the ligand than a given distance (usually 8-12 Å)
[124, 125]. An issue with this approach is that it may lead to signiﬁcant
33
3.3 Employed Free Energy Methods
change in the molecular geometry during minimization. Recently, Kongsted
and Ryde [121] have proposed to use a ﬁxed buﬀer region to prevent the
geometry from being distorted during minimization.
In this thesis, these two MMPBSA improvements have been tested in a
calculation of the binding free energies of HIV protease inhibitor complexes
(subsection 4.2).
34
4 Systems and Applications
4.1 Derivation of Sulphotyrosine Forceﬁeld Parameters
4.1.1 Introduction
The modiﬁed amino acid sulphotyrosine (O-sulphate-L-tyrosine, TYS) is
contained in many important proteins. TYS residues are frequent extracel-
lular modiﬁcations that play roles in many physiological processes including
e.g. blood coagulation, cell attachment or viral entry into host cells [126].
Prominent examples of TYS-containing proteins are the HIV coreceptors
CCR5 and CXCR4. At their N-termini there are several TYS residues that
are essential for the binding of HIV gp120 protein and thus for viral entry
[127]. Molecular dynamics simulations of CCR5 have already been performed
using available phosphotyrosine parameters as an approximation [128]. Al-
though this might work reasonably well, there is a need for more speciﬁc
parameters that model the sulphotyrosine characteristics more accurately.
To this end, TYS atomic partial charges and parameters suited for Cornell
et al. forceﬁelds [32] and its adaptions have newly been derived.
4.1.2 Methods
Restrained electrostatic potential (RESP) atomic charges for N-Acetyl-O-
sulphate-L-tyrosine-N'-methylamide dipeptide (ACE-TYS-NME, capped amino
acid), as well as for the central, (+)NH3-terminal and (-)OOC-terminal frag-
ments of the O-sulphate-L-tyrosine amino acid were calculated using the
R.E.D. IV server [129]. The procedure was executed analogous to the deriva-
tion of O-methyl-L-tyrosine charges described in Dupradeau et al. [130].
Two representative conformations close to those found in α-helix and β-
sheet secondary structures were considered in the procedure [131]. Geome-
try optimization and molecular electrostatic potential (MEP) computation
were carried out using the Gaussian 09 program (revision A.02) [132] in the
gas phase and charge ﬁtting was performed using the RESP program. The
Hartree-Fock (HF) method with a 6-31G* basis set was used in geometry
optimization, while HF/6-31G* and the Connolly surface algorithm were em-
ployed for MEP computation. The molecular orientation of each optimized
geometry was controlled using the rigid-body reorientation algorithm imple-
mented in the R.E.D. program. A geometric restraint was imposed on the
dihedral angle C-CA-CB-CG during quantum-mechanical (QM) minimiza-
tion to prevent the sulphate group from interacting with backbone atoms.
Forceﬁeld parameters were adapted from previously derived phosphotyrosine
parameters [133] available from the Amber parameter database [134]. To this
end, dihedral parameters C-OS-S-O2 and CA-C-OS-S were ﬁtted to a QM
energy proﬁle by a systematic search. The QM energy proﬁle was built from
35 representative conformers where these two dihedral angles were varied
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in steps of 15 degrees (ﬁgure 4.1). The conformers and corresponding QM
energies were provided by Björn Thorwirth and Georg Jansen (University
Duisburg-Essen).
Figure 4.1: Representative Conformers.
4.1.3 Results and Discussion
Figure 4.2 shows the capped sulphotyrosine with the calculated RESP charges.
Figure 4.2: Sulphotyrosine Charges. Important atoms are labeled by
Amber atom type (bold font).
Table 4.1 shows the new set of sulphotyrosine parameters in the format
required in the Amber forceﬁeld modiﬁcation ﬁle (frcmod). Kr, req are
the bond and angle equilibrium lengths and KΦ, Φeq the associated force
constants, respectively. The representation of the torsional potential is
((Vn/2)/nbp) · (1 + cos(np · Φ − γ)) where Vn is the barrier height, nbp is
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the number of bond paths, a factor by which the barrier height is divided, γ
the phase shift angle and np the periodicity of the torsional barrier. Improper
torsions are represented in the same way as the torsions but not divided by
a nbp factor. A more detailed explanation for this representation is given
in Weiner et al. [135]. The sources of parameters are given in brackets.
Pp means that the parameter is adapted from an analogous parm99 phos-
phate parameter [133], P means taken from parm99 [35], G means taken
from GAFF [37], Q means that these parameters are taken from a quantum
energy-minimized structure and C means that these parameters were newly
computed.
Table 4.1: Set of Sulphotyrosine Parameters.
Bonds Atom types Kr req
S-OS 525.0 (Pp) 1.66 (Q)
O2-S 525.0 (Pp) 1.43 (Q)
Angles Atom types KΦ Φeq
C-OS-S 100.0 (Pp) 120.50 (Pp)
CA-C-OS 70.0 (G) 120.00 (G)
O2-S-O2 140.0 (Pp) 119.90 (Pp)
O2-S-OS 100.0 (Pp) 108.23 (Pp)
Dihedrals Atom types Vn/2 nbp γ np
C-OS-S-O2 0.889 (C) 3 0.0 3
CA-C-OS-S 0.333 (C) 2 180.0 2
Impropers Atom types Vn/2 γ np
CA-CA-C-OS 1.1 (P) 180.0 2
As can be seen in ﬁgure 4.3 on the right, the molecular mechanics energies
(yellow) correlate very well with the energies from the quantum mechanics
calculation at the Hartree-Fock level of theory (black dotted bold line) with
r=0.97 and a maximum deviation of 2.3 kJ/mol. They also correlate well
with quantum energies on the B3LYP level (black dotted timid line) indi-
cating that the charges are reasonably consistent with the forceﬁeld ﬀ03.
Furthermore, the calculated charges are consistent with previously derived
charges for O-phosphate-L-tyrosine [133]. As an indication of improvement
over the old parameters, the left ﬁgure shows the correlation of MM versus
QM energies if phosphotyrosine torsion parameters are used.
As a ﬁrst validation, we performed two 50 ns explicit water simulation of
ACE-TYS-NME with the old and new parameter sets. We observed that
the sulphate group is free to rotate (roughly twice per nanosecond). Using
the phosphotyrosine parameters as an approximation, the energy barriers
are much higher and the sulphate group rotated only twice in 50 ns.
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Figure 4.3: Fit of Quantum and Molecular Mechanical Energies.
Left: MM (red) and Hartree-Fock QM (black) potential energies using the
phosphotyrosine torsion parameters. Right) MM (yellow) versus Hartree-
Fock (bold black) and B3LYP (timid black) QM using the new sulphotyrosine
parameters.
4.1.4 Conclusion
Since the charges were derived with state-of-the-art tools consistent with
the derivation procedure of Cornell et al. forceﬁelds [32], the derived atomic
partial charges are of high quality. The procedure for the derivation of miss-
ing forceﬁeld parameters is certainly not perfect and especially not generic.
However, the new parameters are at least a major improvement over the old
onces and should be used when simulating TYS-containing protein systems.
The parameters could certainly be improved by a more thorough optimiza-
tion using for example a genetic algorithm. A ready-to-use protocol for the
derivation of these parameters is not available at present but under develop-
ment [136]. For further validation, TYS-containing protein systems should
be simulated and analyzed for stability of certain crucial geometric features.
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4.2 MMPBSA on HIV Protease Complexes
4.2.1 Introduction
With the methodological MMPBSA improvements outlined at the end of
subsection 3.3.2 it has been tested whether it is now possible to rank binding
aﬃnities correctly. A set of four complexes, a wildtype (WT) and a double
mutant (V82T/I84V, MT) HIV protease complexed with amprenavir (APV)
and darunavir (DRV) where both experimental aﬃnities from isothermal
titration calorimetry (ITC) and crystal structures are available has been
chosen as a test set. The range of the binding energies of these complexes
is relatively narrow (3.5 kcal/mol) compared to other typical test systems
such as congeneric series of Biotin analogues bound to Avidin [120]. This
makes the calculation of a correct ranking very challenging, but it is on the
other hand a real world problem. While the experimental precision of the
free energies is limited and might be insuﬃcient to distinguish the values, the
correctness of the experimental ranking is veriﬁed by the resistance context.
4.2.2 Methods
Preparation of Complexes The HIV-PR simulations of WT-APV, MT-
APV, WT-DRV, and MT-DRV were based on the corresponding crystal
structures with PDB ids. 1HPV, 1T7J, 1T3R, and 1T7I [137, 138], respec-
tively. Two diﬀerent models (A,B) of each system were build by using avail-
able alternate side-chain conformations. Since there are no alternate side-
chain conformations available in 1HPV, crystal structures with PDB ids.
1HPV and additionally 1T7J were used to build two diﬀerent models for
WT-APV. Crystal water molecules were removed, except one structurally
important water molecule between the protease ﬂaps and inhibitor. One
of the catalytic Asp residues was protonated (Asp 25) on the basis of con-
siderations made by Hou et al. [23], whereas all the other Asp and Glu
residues were negatively charged and all Arg and Lys residues were posi-
tively charged. The two His residues were protonated on the NE2 atom.
The protein was described with the Amber03 force ﬁeld [36] and the ligands
with GAFF [37]. The ligands were optimized at the HF/6-31G** level us-
ing Gaussian09 [132]. The electrostatic potential (ESP) was then calculated
at the B3LYP/cc-pVTZ level with the polarizable continuum model [139]
and a dielectric constant of  = 4 at points sampled with the Merz-Kollman
scheme [140]. Point charges were ﬁtted to the ESP using the RESP [141]
procedure with the antechamber program. All complexes were immersed in
a truncated octahedral box of TIP3P water molecules [43] extending 10 Å
from the protein. Finally, ﬁve to seven chlorine ions were added to neutralize
the system.
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Molecular Dynamics Simulations The sander module of Amber 10 was
used for minimization and equilibration and the GPU version of the Amber
11 pmemd module [79] was used for production. The temperature was kept
constant at 300 K using a Langevin thermostat [69] with a collision frequency
of 5 ps−1, and the pressure was kept constant at 1 atm using an anisotropic
scaling barostat [68] with a relaxation time of 1 ps. Particle mesh Ewald
summation [29] was used to treat long range coulombic interactions. The
cutoﬀ for nonbonded interactions was set to 9 Å. The SHAKE algorithm was
used to constrain bonds involving hydrogen atoms allowing for an integration
time step of 2 fs. Water molecules and hydrogen atoms were relaxed ﬁrst
using 100 cycles steepest descent followed by 100 cycles conjugate gradient
with all protein and ligand heavy atoms restrained with a force constant
of 4 kcal mol−1Å−2. The solute was relaxed by 1000 cycles steepest descent
followed by 100 cycles conjugate gradient with no restraints. Initial velocities
were randomly assigned from a Boltzmann distribution. The system was
then gradually heated from 0 to 300 K over 50 ps and equilibrated for another
100 ps in the NVT ensemble. 1.5 ns production simulations were carried
out in the NPT ensemble. It was known from previous calculations that
this simulation length is suﬃcient to converge ∆G estimates to within 0.5
kcal/mol in one individual simulation. For each system equilibration and
production steps were repeated 28 times with both diﬀerent random seeds
(VIIT) and diﬀerent initial water boxes (SIIT).
MMPBSA Implementation and Parameterization The MMPBSA.py
module (Amber 11) was used for the calculation of all enthalpic terms and
a modiﬁed version of the Amber 10 perl implementation (mm_pbsa.pl) to-
gether with additional perl scripts were used for the calculation of the en-
tropy. The terms were calculated with all solvent molecules and ions stripped
oﬀ the trajectory and without any periodic boundary conditions but with an
inﬁnite cutoﬀ. The MM energies were estimated using the same forceﬁeld as
in the simulations. The polar solvation energy was calculated with several
models, namely the Poisson-Boltzmann model with protein dielectric con-
stants set to 1 or 2 using two diﬀerent numerical solvers, the PBSA module
from the Amber software (PB1, PB2) and APBS (APBS1, APBS2), and the
Generalized Born model with a protein dielectric constant set to 1 (GB).
The solvent dielectric constant was set to 80 in all cases. The non-polar
solvation energy was calculated according to ∆Gnp = γSASA+ b with γ =
0.00542 kcal/mol·A˚2 and b = 0.92 kcal/mol [142]. The translational and ro-
tational entropy was calculated with standard statistical mechanics formulas
[81]. The vibrational entropies were estimated using the ideal-gas rigid-rotor
harmonic-oscillator approximation [81]. The systems were minimized before
the frequency calculations. Both the minimization and the frequency calcu-
lations were performed in a vacuum. The vibrational entropy calculations
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were performed using the truncation approach suggested by Kongsted and
Ryde [121] (ﬁgure 4.4). In this approach, all protein residues within a radius
of 8 Å of the ligand (including the ligand itself) are included in the calcu-
lations together with a buﬀer that consists of all residues within 4 Å of the
former residues, as well as all water molecules within 12 Å of the ligand. The
buﬀer is meant to keep the geometry of the complex as close as possible to
the original geometry during minimization.
Figure 4.4: Entropy Calculation Truncation Approach Water
molecules are shown in blue, protein residues that are included in the fre-
quency calculations are shown in green, and protein residues that are in the
buﬀer region are shown in orange. The ligand is shown in ball-and-stick
representation. The protein is fXa. (Illustration adapted from [143] and
produced by Samuel Genheden)
Analysis of the Energy Calculation From the 1.5 ns simulation length,
snapshots in intervals of 10 ps were used for the energy calculation making
a total of 300 snapshots in each individual simulation. For the ﬁnal result
shown in ﬁgure 4.5, 0.5 ns were considered additional equilibration and the
last 1 ns was used to calculate the ensemble averages albeit the dependence
of results on diﬀerent chosen equilibration times has also been considered.
For clarity, the data of each time series was subdivided into 12 blocks of
25 snapshots each (corresponding to a running mean with no overlap). I
have chosen this variant because it formidably preserves the characteristics
(especially the drift) of the data while smoothing out variance from thermal
ﬂuctuation. Alternatively, I have also used cumulative averages and reverse
cumulative averages [144] which tend to hide drifts and give a too optimistic
picture of convergence. The statistical error of the binding free energy esti-
mates is given by the standard error of the mean with n being the number of
simulations. This is deviant from the usual practice of giving the standard
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error of the mean with n being the number of snapshots (e.g. [112]) and it is
characteristically more conservative. The quality of the ranking was assessed
with both the Pearson correlation and Kendalls rank correlation. According
to the Gaussian law of error propagation for independent variables, the ∆G
error bars were calculated as the sum of ∆H and T∆S error bars.
4.2.3 Results and Discussion
Binding aﬃnities for HIV-protease complexes using the MMPBSA method
with ensembles of short simulations and a new entropy approach were cal-
culated. The solvation models Poisson-Boltzmann using the Amber pbsa
solver and APBS both with dielectric constants 2 and 4 and Generalized
Born (dielectric 1) were tested.
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Figure 4.5: Ranking of Binding Aﬃnities. MMPBSA results for the
diﬀerent solvation models PB1, PB2 and GB are shown from top to bottom
(data for APBS not shown). Calculated ∆H and ∆G (including −T∆S)
each vs. experimental aﬃnities [145] are shown on the left and right panels of
ﬁgures, respectively. For each protein-ligand system, the calculated aﬃnities
from models A and B are shown left and right, both with error bars (standard
error of the mean), and the combined average is shown in the middle (black
star). The scaling on the y-axis is equal for all plots.
Ranking of Binding Aﬃnities Generally, the calculated binding aﬃni-
ties have converged to standard errors 0.6-1.1, 0.8-1.1 and 0.8-1.3 kcal/mol
for PB1, PB2 and GB, respectively (ﬁgure 4.5). More simulations would be
needed to reach the desired convergence to below 0.5 kcal/mol that would
establish a statistically valid ranking. Interestingly, in many cases, the error
bars of conformations A and B do not overlap indicating a strong depen-
dence on the initial structures although the diﬀerences of these structures
are relatively marginal.
It is important to note, that the aﬃnity estimates for one same system vary
in the range of roughly 10 kcal/mol for the 28 simulations indicating that the
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values strongly depend on the chosen initial conditions. Calculations that I
conducted previously showed that this circumstance does not change even if
all simulations are prolonged to 10 ns.
The ranking of binding aﬃnities is modest with Pearson correlation coeﬃ-
cients 0.31 (p=0.3), -0.12 (p=0.9) and 0.52 (p=0.5) and Kendalls rank cor-
relation coeﬃcients 0.18, -0.33 and 0.33 for PB1, PB2 and GB, respectively.
However, none of the rankings is signiﬁcant. As must be expected, the ab-
solute binding aﬃnities depend strongly on the solvation models while the
absolute values using PB1 are closest to experiment (-18 to -22 kcal/mol).
Moreover, also the established rankings depend on the solvation models as
is reﬂected by the diﬀerent Kendalls correlations.
Regarding the enthalpies, the APV complexes are clearly distinguished from
the more stable DRV complexes which is probably a consequence of the
favorable contacts of the additional DRV moiety. The large enthalpic exper-
imental diﬀerence of 2.5 kcal/mol between the DRV MT and WT systems is
reproduced by none of the solvation models and the values are almost equal
instead. Also notably, the APV systems are more clearly distinguished from
the DRV complexes by the GB model than by the PB model. However, the
absolute enthalpic diﬀerence seems to be overestimated here. Surprisingly,
the ranking of enthalpies of APV MT and WT systems is systematically
wrong. The APBS solver (data not shown) generally gives larger ﬂuctua-
tions than the Amber pbsa solver and there were outliers in some cases. The
cause of these outliers could not be determined.
Time Dependence of Calculated Aﬃnities The dependence of en-
thalpic energies on diﬀerent equilibration and production times were con-
sidered (ﬁgure 4.6). While the energies typically change in the ﬁrst 250 ps
(blocks 1 and 2) due to structural rearrangements, they are reasonably stable
over the rest of simulation time. Averages from blocks 3-4 are highly corre-
lated to the averages from blocks 5-12 (r=0.94-0.98). It can also be observed
that APV complexes are by trend destabilized while the energies of the DRV
complexes are more or less constant. The accuracy of the enthalpy values
are lower than the aimed 0.5 kcal/mol in 7 of 8 complexes in the ﬁrst 250 ps
of the simulations but exceeds 0.5 kcal/mol in the further time course (data
not shown), probably because the simulations diverge into diﬀerent confor-
mational subspaces. The GB results typically have larger variation than the
PB results indicating that the GB model is more sensitive to conformational
diﬀerences than the PB models. This eﬀect can also be seen in the data of
Genheden et al. [104].
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Figure 4.6: Time Dependence of Calculated Aﬃnities. Results for
the diﬀerent solvation models PB1, PB2 and GB are shown from top to
bottom. Left) Timeseries of ∆H blockwise averages. Right) Correlation of
averages from blocks 3-4 and blocks 5-12.
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Correlations between solvation models are shown in ﬁgure 4.7. The highest
correlation (0.87) is observed for GB versus PB1, probably because the GB
model is parameterized against an internal dielectric of 1.
Figure 4.7: Correlation of calculated ∆H between the diﬀerent solvation
models. Blockwise averages from all systems were plotted.
Entropies from Truncation Approach The time dependence of cal-
culated entropies is shown in ﬁgure 4.8. Compared to the enthalpies, the
entropies are relatively stable over time. Interestingly, for the APV com-
plexes, entropies are pretty much equal in the ﬁrst half of the simulations
while they tend to diﬀer in the second half of the simulations. The standard
error of the mean is very low (0.3 kcal/mol) compared to typical results from
the conventional approach with no truncation and no water buﬀer.
Figure 4.8: Entropy from Truncation Approach. On the left: Entropic
component T∆S , on the right: standard error of the mean T∆S.
A more detailed analysis of the truncation entropy approach has additionally
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been performed comprising analysis of the impact of buﬀer region, truncation
radius and dielectric constant and was published in the Journal of Chemical
Information and Modeling [143]. As a main result, this study shows, that
while the truncation approach gives systematically lower entropies, the cal-
culated relative aﬃnities are not aﬀected by the truncation and the estimates
are typically much more precise, making the calculation more eﬃcient.
4.2.4 Conclusion
A general important conclusion that has to be drawn from this study is that
multiple trajectories are necessary to converge MMPBSA estimates with
respect to the varying arbitrarily chosen initial conditions. I experienced that
virtually all results from the literature that are based on only one simulation
per system are not reproducible because the simulations depend on initial
conditions, namely the conformation of the starting structure, the random
velocity distribution of atoms and the conﬁguration of the initial water box.
Since the calculated aﬃnities signiﬁcantly depend on marginal structural
diﬀerences of some rotamers of a small number of sidechains, it might be
a better strategy to use one same starting structure and model the point
mutations to calculate the relative aﬃnities.
Furthermore, I conclude that using ensembles of simulations, while improving
convergence, is still not a profound solution to fully converge MMPBSA
estimates because the distributions of rotamers, especially those of buried
side-chains, still depend on the initial rotamers. The time scale for rotation
of buried side chains is 10−4 to 1 second. Hence, a complete Boltzmann-
distributed ensembles seems to be far out of reach. Additionally, even more
simulations would be needed to converge the estimates below 0.5 kcal/mol.
As a consequence of its intrinsic imprecision, MMPBSA type calculations
are not more eﬃcient than rigorous free energy calculations which should be
preferred if its possible. The truncation approach gives more precise entropy
estimates than the conventional entropy approach and is a proper approach
to increase the eﬃciency of NMA entropy calculations.
Further uncertainties exist in this study that hamper the evaluation of its
outcome. Although the protonation state of the catalytic aspartates was cho-
sen upon reasonable considerations, its validity is not guaranteed and this
could possibly aﬀect the calculated aﬃnities. More importantly, the miss-
ing forceﬁeld parameters for the inhibitors were taken from GAFF and not
further validated. A consistent validated set of parameters for the approved
HIV protease inhibitors would be of great value because the HIV protease
serves as a prominent model system for numerous molecular dynamics inves-
tigations.
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4.3 L76V Thermodynamic Integration Calculation
4.3.1 Introduction
An interesting mutation of the HIV protease is L76V. It has ﬁrst been ob-
served as a resistance mutation against the three inhibitors lopinavir, am-
prenavir and darunavir. Surprisingly, it turned out that L76V resensitivates
the HIV protease against saquinavir and atazanavir (ATV). Hence, the L76V
mutation is of direct therapeutic relevance and clinicians have strong interest
in an explanation for this eﬀect at the molecular level. Unfortunately, the
relative free energy change could not be reproduced with MMPBSA calcu-
lations. In this work we investigated whether it is possible to capture the
hypersensitization eﬀect of the HIV-PR L76V mutation against ATV [146]
using rigorous free energy calculation, and we chose thermodynamic integra-
tion (TI). The free energy diﬀerence for the wildtype has not been measured
(at least not at the time of this study) and is only indirectly derived from
z-score data out of geno2pheno [8] predictions. A z-score value has been de-
termined by Alcaro et al. to -0.3 [147] corresponding to a free energy change
of approximately 1 kcal/mol. In accordance to TI (explained in subsubsec-
tion 3.3.1), the relative free energy diﬀerence can be calculated from two
transformations, one in the bound and one in the free state:
∆∆Gbind,L76V = ∆GL76,binding−∆GV 76,binding = ∆GL76V,bound−∆GL76V,free
(4.1)
The L76-ATV (wildtype inhibitor complex) should be less stable than the
V76-ATV (mutant inhibitor complex). Thus, if the calculation comes out
right, a positive ∆∆Gbind,L76V has to be expected (corresponding to a neg-
ative z-score value), e.g.
∆∆Gbind,L76V = ∆GL76,binding −∆GV 76,binding = −12− (−13) = 1 (4.2)
4.3.2 Methods
Preparation of Input Files All calculations were conducted using Amber
10. HIV protease ATV complex models were built based on the crystal
structure with PDB id. 2AQU [148]. One of the catalytic Asp residues
was protonated (Asp 25), whereas all the other Asp and Glu residues were
negatively charged and all Arg and Lys residues were positively charged.
The two His residues were protonated on the NE2 atom. The protein was
described with the Amber03 force ﬁeld [36] and the ligands with GAFF. The
ligands were optimized at the HF/6-31G** level using Gaussian09 [132]. The
electrostatic potential (ESP) was then calculated at the B3LYP/cc-pVTZ
level with the polarizable continuum model [139] and a dielectric constant of
 = 4 at points sampled with the Merz-Kollman scheme [140]. Point charges
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were ﬁtted to the ESP using the RESP [141] procedure with the antechamber
program. All complexes were immersed in a truncated octahedral box of
TIP3P water molecules [43] extending 12 Å from the protein. Finally, eight
chlorine ions were added to neutralize the system. Parameter and coordinate
ﬁles were built as follows: In a ﬁrst leap run, two pdb ﬁles were created
with solvated and neutralized receptor and complex wildtype (L76) systems.
Then, the additional methyl group atoms and the Cβ atom were removed
from these pdb ﬁles (in both monomers) and these LEU residues renamed to
VAL yielding the mutant receptor and complex pdb ﬁles. The valine atoms
added by leap were remodelled with Pymol [149] to get maximum overlap
with the leucine residues. In a second leap run, topology and coordinate
(restart) ﬁles were created for all four systems.
Free Energy Calculation The free energy was calculated according to
the TI scheme described in subsubsection 3.3.1. Both transformations in the
bound and unbound state were subdivided into three subtransformations for
switching oﬀ partial charges on L76, transforming van der Waals parameters,
and switching on the partial charges for V76. For each subtransformation,
sampling was performed at λ = 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8 and 0.9.
Values for λ = 0 and 1 were extrapolated using the trapezoid rule. The
total free energy is obtained by summing over all λ values. The following
λ-dependent soft-core potential [150] was used for the van der Waals param-
eters of coupled atoms
Vsoftcore_vdW = 4(1− λ)
[
1
[αλ+ (r/σ)6]2
− 1
αλ+ (r/σ)6
]
(4.3)
where  and σ are the common Lennard-Jones parameters, r is the inter-
atomic distance and α is an adjustable constant set to 0.5. No softcore
potential for Coulombic interactions was used.
MD Simulations The multisander module was used for all simulations.
The temperature was kept constant at 300 K using a Langevin thermostat
[69] with a collision frequency of 5 ps−1, and the pressure was kept constant
at 1 atm using an anisotropic scaling barostat [68] with a relaxation time
of 1 ps. Particle mesh Ewald summation [29] was used to treat long range
Coulombic interactions. The cutoﬀ for nonbonded interactions was set to 9
Å. The SHAKE algorithm was used to constrain bonds involving hydrogen
atoms allowing for an integration time step of 2 fs. The whole system was
minimized by 500 cycles steepest descent. Initial velocities were randomly
assigned from a Boltzmann distribution. The density was then equilibrated
for 25 ps in the NVT ensemble while heating the system gradually from 0 to
300 K. For each λ step of each subtransformation 6 ns production simulations
were carried out in the NPT ensemble. The last 3 ns were used for the energy
calculation.
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4.3.3 Results and Discussion
Resulting dV/dλ curves are shown in ﬁgure 4.9.
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Figure 4.9: dV/dλ curves assembled from 9 λ points each. The three
transformations, turning oﬀ charges on L76, transforming vdW parameters
and turning on charges on V76 are shown from top to bottom (named step1,
step2 and step3). Bound and unbound transformation and the resulting
diﬀerence are shown from left to right (named com, rec and com-rec).
It can be seen that the curves are generally relatively smooth indicating
suﬃcient convergence. The electrostatics transformations are particularly
smooth with very low standard deviations. This is reasonable because the
partial charges of the changing atoms from the hydrophobic residues leucine
to valine are very small. Accordingly, the free energy of electrostatic trans-
formations are close to zero (-0.14 and 0.41 kcal/mol). However, there is a
substantial free energy change for the van der Waals transformation. The
kink in the dV/dλ curve for this transformation indicates that there might
be an abrupt conformational change. From visual inspection alone, how-
ever, this conformational change cannot be ﬁgured out and more advanced
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analysis would be needed to understand the mechanistic eﬀect of the L76V
mutation.
Free energy changes calculated for the three transformations are shown in
table 4.2. The total free energy change (1.53 kcal/mol) corresponds well to
the expected experimental value (1 kcal/mol). Most importantly, the trend
of the free energy change is correct identifying the L76V mutant as a stronger
binder to ATV than the wildtype.
step free energy change ∆G (kcal/mol)
1 -0.14
2 1.26
3 0.41
total 1.53
Table 4.2: Thermodynamic Integration Results.
4.3.4 Conclusion
Since the structural change introduced by the L76V mutation is rather small,
this was a good example where TI could work. The TI calculation roughly
reproduces the expected free energy change of 1 kcal/mol. Given that such
a small free energy diﬀerence is approximately the margin of error for a
TI calculation on biological systems, this is a pretty good result. Error
estimation for TI is a tricky thing to do [150] and I left it with giving the
standard errors for dV/dλ values for the transformations. However, the
smoothness of the dV/dλ curves suggests that the result is not by chance.
A justiﬁed criticism to this study is the choice of the initial structure for the
simulations of the free receptor state which has been taken from the HIV-
ATZ complex with ATZ coordinates stripped oﬀ. It is well known that the
apo HIV protease ﬂaps adopt a semi-open conformation [151] and the chosen
initial structure does possibly not sample the correct free equilibrium state.
A mechanistic understanding of conformational rearrangement induced by
the L76V mutation underlying the observed free energy change would be
desirable. Although the transformation paths are unphysical, it could nev-
ertheless well be valuable to do some form of distance analysis on this data.
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4.4.1 Introduction
The aim of the following study is to explain a set of interesting resistance
data for the HCV protease, a major drug target for the therapy of Hepati-
tis C, from a mechanical point of view. The most crucial experience that
I got from the MMPBSA calculations is that the calculated energies de-
pend severely on the simulations initial conditions such as the randomly set
starting velocities of the atoms, the conﬁguration of the water box and the
starting conformation. Since the MMPBSA energies depend on such initial
conditions, it is also clear that geometrical features like distances, angles or
root mean square ﬂuctuations have similar convergence issues. From this
experience, it is natural to not rely on the outcome of single simulations but
rather use ensembles of multiple simulations instead. Hence, I have used
a set of simulations for each protein system instead of only one simulation
and evaluated the geometrical diﬀerences with a multiple testing approach.
I start here by giving a topological overview of the protease structure and its
speciﬁc characteristics. Subsequently, I discuss the available new resistance
data and revisit an explanation of resistance mechanisms against BILN that
is considered useful for this study. Then, I report on the simulation setup
that I have performed and the analysis of geometrical features.
The HCV NS3-4A Protease Molecule The NS3 serine protease (HCV
protease) is contained within the N-terminal 180 amino acid residues of the
NS3 protein [152]. The C-terminal part (residues 180-630) of the NS3 protein
has a helicase function. Crystallographic structures of the NS3 protease
domain with [153] and without [154] the cofactor 4A have ﬁrst been solved
in 1996. The NS3 protease domain forms a double-barrel fold similar to that
of serine proteases from the chymotrypsin/trypsin super-family with one
N-terminal eight stranded (residues 1-93) and one C-terminal six stranded
(residues 94-180) anti-parallel β-barrel (ﬁgure 4.10). The catalytic site is
situated in the crevice between the two domains and is formed by the triad
of residues H57, D81 on the N-terminal and S139 on the C-terminal domain.
The NS4A cofactor peptide is one of the eight strands of the N-terminal β-
barrel. The C-terminal domain contains one zinc binding domain at one end
opposite to the catalytic triad. Two helices, α1 (residues 56-60) comprising
the catalytic His57, and α2 (residues 131-137) are present with and without
NS4A. Two additional helices, α0 (residues 13-21) and α3 (residues 172-180),
are formed only in the NS3-4A complex structure.
From a comparison of Cα distances of the three catalytic site residues be-
tween NS3-4A and other serine proteases, it can be seen that while the
distances are generally comparable, the His-Ser distance is relatively long
compared to other small serine proteases [155]. This notion supports the hy-
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Figure 4.10: Structural Overview of NS3-4A. The ﬁgure is based on
the initial energy-minimized structure that was used for the simulations. The
catalytic serine is already remodelled. The ﬁgure on the right is rotated 90°
around the horizontal axis with respect to the ﬁgure on the left. Secondary
structure elements are colored green. The cofactor NS4A that is connected to
the protease via a linker is shown in pink. Active site residues and resistance
mutations are colored orange and red, respectively. Helices are labeled αn
and two important β-strands are labeled E1 and F1.
pothesis that the substrate induces proper active site geometry upon bind-
ing. The commonly accepted mechanistic model of action of the serine
proteinases implies a relay mechanism of hydrogen bonds involving, on one
side, the carboxylate moiety of the Asp and the delta-HN of the His residue
and, on the other side, the epsilon-N of the His and the gamma-HO of the
Ser residues. This relay of H-bonds activates the gamma-O of the serine
residue, which can produce the nucleophilic attack on the C atom of the
scissile bond. [155]
Role of the NS4A Cofactor NS4A is a cofactor that has been shown to
enhance protease activity in all cleavages via formation of a NS3-4A complex.
Interaction with the NS4A cofactor is required to perform the cleavages at
NS3/NS4A, NS4A/NS4B, and NS4B/NS5A junctions but the protease in
its uncomplexed state is still able to cleave at the NS5A/NS5B boundaries,
although with much lower activity [155]. A kinetic analysis conducted on
diﬀerent types of substrate-like inhibitors in the absence and presence of the
NS4A cofactor has shown that the action of NS4A peptide is exerted only on
the P'-side of the substrate [156]. From these ﬁndings, the authors conclude
that NS4 modulates NS3 activity by alteration of the S' subsites. In the
Barbato 1999 NMR structure set of the NS3 protease without cofactor [155],
the N-terminal β-barrel seems to be less compact than the C-terminal one
(ﬁgure 4.11). The mechanistic role of NS4A and substrate in the activation
of the HCV NS3 protease has also been investigated by MD simulations
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Figure 4.11: NMR Ensemble of
HCV Protease without Cofactor
NS4A. Strands A1-F1 are in the N-
terminal and A2-F2 are in the C-
terminal β-barrel [155].
[157]. Eventually, the NS4 cofactor has to be regarded as an integral part of
the protein and has therefore no more particular role than the other protein
parts.
Structure and Role of the Zinc Binding Domain In contrary to zinc
proteases, the zinc binding in the HCV protease is generally believed to have
only a structure-stabilizing role. It has been shown that the NS3 protein does
not fold properly in the absence of zinc and is catalytically deﬁcient [158].
The zinc-binding site in solution undergoes conformational exchange between
an open and a closed conformation by switching the side-chain of His149 on
the hundreds of milliseconds timescale [155]. There was some controversy on
the His coordination site of the zinc. From the ﬁrst crystal structures of NS3
and NS3-4A, the presence of a bridging water was postulated because the
imidazole ring is too distant from the zinc ion [154]. In the NMR structure
set of Barbato et al. [155] the imidazole ring directly coordinates the zinc ion.
In the new substrate-bound crystal structures [16] the zinc ion is coordinated
by the His via a bridging water.
Substrate Speciﬁcity NS3-4A is responsible for cleavage at four sites
4.12.
Figure 4.12: Sequences of HCV Protease Substrate Cleavage Sites.
Table from Romano et al. [16].
Unusually long substrates (P6-P4') are required for eﬀective cleavage [159].
Importantly, there is always an acid (predominantly D/E) at P6, Cys/Thr
at P1 and Ser/Ala at P1'.
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Further Relevant Observations from the Literature The loop with
the three residues 79-81 is solvent-exposed in the apo structure and has high
temperature factors indicating a high degree of mobility [155, 16]. Hence, the
hydrogen bond between the carboxylate group of Asp81 and the delta-NH of
the His57 is not stable in the apo structure. It is generally believed that the
Asp81 has to be shielded for the formation of a proper active site geometry.
In fact, there are always large hydrophobic residues at the substrates P2 sites
of small serine proteases. This residue together with the aliphatic methylene
groups of R155 could contribute to shelter the Asp81. Helix α3 is crucial for
the correct packing of the strand F1 that positions the catalytic Asp81 [160].
In many of the conformations from the Barbato NMR structure set, there
is an alternative conformation in which the β-sheet is twisted and Asp79
coordinates the catalytic His57 instead of Asp81. This could possibly be
an alternative mode of His coordination. Given the fact that Asp79 is only
conserved in HCV genotype 1 this could be a reason why the genotype 1 is
more robust than the other genotypes. It is also worth noting that the residue
position 71 is polymorphic in the wildtype. Several hydrophobic residues, in
particular I, V and L have been observed [152]. In direct proximity, I72 and
T72 instead of V72 have also been observed.
Substrate-bound Structure Recently, structures of complexes of HCV
protease with the N-terminal product of the four natural peptide substrates
were solved [16] at resolutions 1.6-1.9 Å. For this structure determination,
the NS3-4A single-chain construct was used in which the essential NS4A
cofactor is covalently linked to the N-terminus by a ﬂexible linker. The
catalytic serine has been substituted with an alanine to prevent catalysis
[16]. Because even with this substitution, the P7-P5' substrate was cleaved,
presumably mediated by a water molecule, only the complex with the N-
terminal cleavage product P7-P1 could be determined [16].
The availability of this structure gives us the opportunity to not only investi-
gate the mutation-induced geometrical diﬀerences on the apo structures but
also on the substrate-bound state. This is particularly relevant because the
I71T mutation might aﬀect the active site, and it has been pointed out that
the N-terminal substrate possibly induces proper active site geometry.
For this study, I have used one of these structures, the one with the 4B5A
substrate, as template (ﬁgure 4.13) because it has a particularly direct re-
lationship to the mutation R123K. In all structures but product complex
4B5A, K165 forms salt-bridges with the P6 acids, while residues R123, D168,
R155, and the catalytic D81 form an ionic network along one surface of the
bound products. In complex 4B5A, R123 interacts directly with the P6 acid,
while D168 reorients and no longer contacts R155. [16].
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Figure 4.13: HCV
protease complexed
with the N-terminal
product of the 4B-
5A substrate. The
product is depicted with
its van der Waals vol-
ume. Major resistance
mutations are shown as
sticks. The direct po-
lar contact between the
substrate and Arg123 is
shown as a red dash
(PDB id 3M5N).
Resistance Proﬁle against BILN In in vitro studies conducted by Jörg
Timm at the University Clinical Center Essen, the following resistance proﬁle
has been found (ﬁgure 4.14) (unpublished data):
Figure 4.14: Resistance to the HCV protease inhibitor BILN2061.
The proﬁle shows the replication rate for each protease variant in depen-
dence to diﬀerent drug concentrations. Rightmost is the data of the wildtype
(con1) as reference. Other bar plots show the resistance proﬁle of diﬀerent
combinations of mutations that were investigated in in vitro studies.
It is experimental evidence that the mutation I71T promotes viral ﬁtness
when occurring along with two resistance mutations R123K and D168V in
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HCV protease while it is lethal to the virus as a single mutation.
Given the primary resistance mutation D168V, under ongoing drug pres-
sure, two further mutations, R123K and I71T, emerge leading to succes-
sively increased ﬁtness. Surprisingly, a R123K single mutant has signiﬁ-
cantly decreased ﬁtness and a I71T single mutant is not viable at all. Also
the D186V/I71T double mutant is not viable. Only the triple mutant is vi-
able when the I71T mutation is present. Because the two further mutations
are not resistance mutations by themselves, it seems that they compensate
the ﬁtness-decreasing eﬀect of the primary resistance mutation in some way.
An astonishing fact is, that the I71T mutation is situated roughly at the
opposite of the molecule from the resistance mutations. Characteristically,
long-range eﬀects are more diﬃcult to explain from any type of analysis. On
the other hand, much could be learned if the full compensatory eﬀect can be
explained.
Resistance Mechanism against BILN A circumstance that hampers
the development of inhibitors for the HCV protease is its shallow binding
site. The ﬁrst proof-of-concept inhibitor against NS3-4A was the macrocyclic
BILN2061 (BILN) [161]. It was found to induce, withing 48 h, 2-3 log10 viral
load reduction in HCV infected patients. It was, however, stopped in a Phase
II clinical trial (in 2005) due to drug-induced cardiac toxicity. More recently,
other PIs have emerged such as VX-950 and SCH-6. However, BILN-2061 is
still a reference compound for HCV-related PIs [162].
Courcambeck et al [162] have described the molecular mechanisms of four re-
sistance mutations R155Q, A156T, D168A and D168V that had been found
in vitro previously [163, 164, 165] (ﬁgure 4.15). The authors distinguish a
direct mechanism for R155Q and A156T because these residues physically
contact the inhibitor, and an indirect mechanism for D168A and D168V
because Asp168 interacts with residues connected to the drug (Arg155 and
Arg123). Arg123 and Val158 deﬁne a solvent exposed binding pocket for
BILNs hydrophobic cyclopentyl moiety. Arg123 participates in the orienta-
tion of this moiety towards Val158. Arg155 exhibits both hydrophilic (alkyl
side chain) and polar (guanidinium side chain extremity) characteristics and
contracts with BILNs P2 moiety these two types of interactions together with
additional pi-pi interactions resulting in a strong important contact. R155Q
modiﬁes the hydrophobic and electrostatic environments of BILNs S2 bind-
ing pocket. Gln155 is uncharged, whereas Arg155 is positively charged on
its guanidinium moiety. The electrostatic interaction between Arg155 and
BILN are therefore disrupted in the R155Q mutant. In the case of the A156T
mutation, the molecular mechanism of viral resistance to BILN relies on a
steric conﬂict. D168A prevents the formation of two salt-bridges between
Asp168 and Arg123 as well as between Asp168 and Arg155. While Asp168
does not signiﬁcantly interact with BILN, it stabilizes the conformations of
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Figure 4.15: Resistance against BILN. A) Two dimensional chemical
structure of BILN with schematic representation of its P1 to P4 binding
moieties. B) HCV protease complexed with inhibitor BILN. BILN, active
site residues and residues relevant to inhibitor binding are shown as ball-
and-stick. Hydrogen bonds are highlighted as green and salt-bridges and
electrostatic interactions as yellow dashes. The ﬁgure is adapted from Cour-
cambeck et al. 2006 [162].
both Arg155 and Arg123. In the D168A mutant, Arg123 is exposed to the
solvent and no more orients the BILN cyclopentyl moiety towards the Val158.
D168V introduces some additional unfavorable van der Waals interactions
(steric repulsion) with Arg155 and with R123 compared to D168A. Hence,
R123 is even more solvent-exposed and no more orients Val158 to make the
van der Waals contact to BILN.
Putative eﬀect of the R123K mutation Next, we consider the muta-
tion R123K in the context of substrate binding (ﬁgure 4.16). In the D168V
single mutant, Arg123 is no more pre-positioned by D168 and is free to move
making a 123-P6 contact harder to be established, possibly leading to a loss
of ﬁtness. With the shorter lysine side-chain in the D168V/R123K double
mutant, formation of such a contact becomes more probable again. Ad-
ditional van der Waals packing of Val168 with P4-Val may strengthen the
contact and improve the positioning of the substrate in a slightly diﬀerent
mode. On the contrary, R123K is unfavorable as a single mutation because
the lysine side-chain is too short giving rise to a steric conﬂict of D168 with
P4-Val and preventing contact formation. This might be the reason why the
R123K single mutant has low ﬁtness with and without drug pressure.
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Figure 4.16: Protease-Substrate Contact 123-P6. The left-hand side
ﬁgure shows the wildtype in which the R123-P6 contact is established (yellow
dotted line). In the right-hand side ﬁgure, D168V and R123K mutations
are indicated by simple side-chain substitutions. Van der Waals volumes of
residue 168 and P4-Val are indicated as dotted spheres.
The compensatory mutation I71T was ﬁrst mentioned by Lu et al [165].
How mutations at these non-active-site positions could impact BILN 2061
binding, if there is any eﬀect, is unclear. The location of residues 71, 72,
and 88 near the NS4A activation protein suggests that they may play a
role in inﬂuencing enzyme activation, but further experimentation would be
required to evaluate this possibility. The mechanism was however so far
not further investigated. It has been stated that T72I and P88L possibly
have a comparable eﬀect as I71T, presumably increasing the E1/F1 β-sheet
ﬂexibility inﬂuencing the His57-coordinating Asp81.
Using a multiple testing approach on multiple trajectories To per-
form a robust analysis of protein dynamics properties, especially when in-
vestigating distal eﬀects of mutations [166], multiple simulation approaches
(or ensemble approaches) were shown to be useful in diverse MD simula-
tion studies including conformational sampling in general [167, 168], rigor-
ous [169, 170, 171] and end-state [120, 112, 143] free energy calculations and
mechanistic trajectory analysis [166, 157]. In the majority of these studies,
the production phases of the several simulations are concatenated to a macro-
trajectory. Given that the single simulations get trapped in energy minima
and are thus not independent from each other, this approach might be disad-
vantageous for t-testing where the independence of values is a prerequisite.
This may lead to a large number of false positives when analyzing geometric
features because the distributions get unrealistically sharp. Instead, it might
be an improvement to regard only the values from simulations with varying
initial conditions to be truly independent from each other.
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4.4.2 Methods
Setup of MD Simulations A set of MD simulations was conducted. All
simulations were based on the HCV protease structure complexed with its
4B5A N-terminal product (PDB id 3M5N). This structure is one of the
highest resolution structures of HCV protease reported to date [16]. It con-
tains four protease molecules and three of them have the N-terminal product
bound (chains F, G and H). Both apo and holo type were considered. In
a ﬁrst set of simulations, the inactivating Ala was not remodelled to serine
because I wanted the initial structure to stay close to the crystal structure.
However, in the course of analysis, the impression emerged that the active
site serine is crucial to the compensatory eﬀect. Hence, in a second run, it
was planned to model the apo type as an active protease and the holo type
as intermediary state where the products C-terminus is covalently bound to
the catalytic serine as illustrated in Barbato et al. [160]. The active apo state
simulations were accomplished and used for analysis. However, for the holo
state, I would have needed the Amber software version 12 which makes it
possible to use restraints in the GPU version of pmemd (pmemd.cuda). For
both apo and holo types, eight receptor variants, the wildtype, single mu-
tants D168V, R123K and double mutant D168V/R123K, with and without
the I71T mutation, were considered. For each of these 16 systems, 12 inde-
pendent simulations, F, G and H complexes, each with four diﬀerent velocity
random seeds, were performed to provide a means to ﬁgure out statistically
relevant diﬀerences.
Preparation of Complexes and MD Simulation From all template
structures, the poly-lysine tail was removed. All crystal waters were also
removed except the bridging water between the His149 and the zinc ion.
The zinc coordination site was modelled using the cationic dummy atom
method [172], i.e. the 2+ charge of the zinc ion is not commonly modelled
as a point charge on the atom center but distributed on four tetrahedrally
liganded dummy cations with no mass. This approach mimics the zinc's
4s4p3 orbitals that accommodate lone-pair electrons and it has been shown
to preserve best the geometric arrangement of protein regions with bounded
zinc ions. For the apo type, the product peptide was removed and for the
active state simulations Ala139 was resubstituted by a serine. The catalytic
His57 is delta-N monoprotonated. All the mutations (S1, S2, DT w/o I71T)
were built by side-chain substitution conducted using the Pymol mutagenesis
feature [149].
All protein residues (except the ones constituting the zinc coordination site)
were parameterized using the Amber ﬀ99SBildn forceﬁeld [32, 35, 173]. The
complexes were solvated in octahedral boxes of TIP3P water molecules [43]
with a minimum distance of 10 Å between the solute and the box boundary.
Amber11 [79] was used for all simulations. Water, hydrogens and all built
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atoms were minimized by 100 steps steepest descent. Water and hydrogens
were then equilibrated over 20 ps NVT. Side-chains were equilibrated over
30 ps NVT. The whole system was equilibrated 50 ps NVT and 50 ps NPT.
Then, 5 ns production simulations were performed at 300 K, 1 bar and 2
fs integration time step in the NPT ensemble using a Langevin thermostat
[69] with a collision frequency of 5 ps−1 and a Berendsen barostat [68].
Electrostatic interactions were calculated using the PME [29] summation
scheme. The cutoﬀ for non-bonded interactions was set to 8 Å. Snapshots
were recorded any 1 ps. The total number of simulations is 192 and the total
production simulation time is 960 ns. All simulations were performed on a
compute node with two Tesla M2050 GPUs using pmemd.cuda.
Signiﬁcant Diﬀerences of Distances and RMSF Several data sets of
distances and residue RMSF were investigated using the signiﬁcance analy-
sis of microarrays (SAM) method (subsubsection 2.5.3) for multiple testing.
The distance data sets were deﬁned considering the chemico-physical context.
To ﬁnd out if the overall geometry has changed Cα distances were analyzed.
Three data sets of Cα distances with ranges < 4 Å (short), 10-12 Å (middle)
and 24-25 Å (long) were deﬁned. Hydrogen bonds and salt bridges were an-
alyzed by deﬁning sets of H-O and N-O distances, respectively, both in the
range < 4 Å. The integrity of the hydrophobic core was investigated by deﬁn-
ing a set of C-C atoms of exclusively hydrophobic residues in the distance
range < 4.6 Å. In principle, any atom-atom distance could be used as feature,
but this would be much more compute-intensive than using only subsets of
distances. Instead, the range of distances for the Cα atoms has been chosen
to have a reasonable coverage of distances representing the geometry. The
sets are illustrated in ﬁgure 4.17.
The data from all distance timeseries from each 5 ns simulation was subdi-
vided into three blocks, the ﬁrst nanosecond, nanoseconds 2-3 and nanosec-
onds 4-5. This is in order to assess if the set of signiﬁcant diﬀerences obtained
by the signiﬁcance analysis changes over time and in particular if the eﬀects
introduced by the modelling of the point mutations needs further time to
equilibrate. From these blocks, the averages and variances were calculated
from each single simulation. To ﬁgure out diﬀerences induced by point mu-
tations, the data has been rearranged into SAM input data sets that each
oppose 48 simulations with and 48 simulations without the mutation un-
der consideration, namely with and without the I71T, R123K and D168V
mutations. Further compilations were also considered, namely sets oppos-
ing the three single mutants versus wildtype, lethal versus viable variants,
double mutant versus wildtype, triple mutant versus wildtype and triple mu-
tant versus wildtype. There is however in these setups a considerably lower
amount of data available, only 12 versus 12 simulations rendering statistical
analysis less powerful.
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Figure 4.17: Distance sets for the SAM analysis. Figures on top
from left to right show the short, middle and long range Cα distance sets.
Figures on bottom show from left to right the H-O, N-O and hydrophobic
C-C distances.
Signiﬁcant Diﬀerences of Concerted Motions Correlated motions from
a distance covariance (DiCC) were measured as described in subsection 2.5.4.
The analysis was based on all Cα-Cα atom pairs. The sets of DiCC values
were used as feature sets for a SAM analysis analogous to the distance anal-
ysis described above.
4.4.3 Results and Discussion
Stability of the Simulations The general stability of simulations has
been assessed by the Cα RMSD (ﬁgure 4.18, black curves). RMSD values are
in the range of 1-1.5 Å with a moderate increase and divergence. This means
that the simulations are stable and all simulations naturally tend to move
away from the geometry of the starting structure exploring conformational
space.
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Figure 4.18: Root Mean Square Deviation. RMSD of MD snapshots
with respect to the starting structure based on a common Cα alignment (left
ﬁgure) and based on an alignment to residues with RMSF < 0.5 Å (right
ﬁgure). RMSD from all residues, from residues with RMSF < 0.5 Å and
residues with RMSF > 0.5 Å are colored black, red and green, respectively.
The calculation of DiCC values was based on an alignment to residues with
low RMSF in order to increase the positional variances of exterior residues.
The cutoﬀ for the deﬁnition of residues with low RMSF was chosen as the
maximum of the RMSF density function (ﬁgure 4.19, right). These residues
resemble roughly the stable core of the protein (ﬁgure 4.20). While the
RMSD diﬀerence of the low-RMSF alignment to a common Cα alignment is
marginal (2 ∗ 10−3 Å), there is at least a modest increase of RMSD in the
exterior protein residues (ﬁgure 4.18, green curve) that might lead to the
detection of an increased number of signiﬁcant DiCC diﬀerences.
Root Mean Square Fluctuation Figure 4.19 shows on the left a RMSF
comparison of apo and holo simulations. The residue ﬂuctuations in the re-
gion 120-152 are increased for the apo simulations. This means that these
residues are more free to move because the substrate is not bound. Fur-
ther comparisons were accomplished in the search for RMSF diﬀerences that
are induced by the mutations under investigation. There are however no
signiﬁcant diﬀerences to be found.
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Figure 4.19: Root Mean Square Fluctuations. Left) RMSF from 48
apo and 48 holo simulations are colored black and red, respectively. Right)
RMSF density function from all apo simulations.
Figure 4.20: Low RMSF
Residues. Residues with low
and high RMSF deﬁned by
a cutoﬀ of 0.5 Å are colored
blue and green, respectively.
SAM Trajectory Analysis - Distances and RMSF Distance averages,
distance variances and RMSF were analyzed using the SAM method based
on the data from the apo simulations with a correct active site geometry.
The result of the signiﬁcance analysis is illustrated in ﬁgure 4.21.
Generally, it can be stated that virtually all diﬀerences that are called signif-
icant by SAM are either in spatial proximity to the investigated mutations
or, if the diﬀerences are over a long range, they have a traceable reference to
it indicating a low level of false positives. This is not trivial because typical
simpler feature analysis suﬀer from false positives caused by large motions
of regions with high thermal ﬂuctuation, e.g. loop regions. Such type of
false positives is however successfully suppressed by the applied procedure.
Furthermore, the sets of signiﬁcant diﬀerences based on data from the three
diﬀerent time intervals are pretty much comparable. Taking into account,
that the apo simulations were based on the holo structure with the sub-
strate removed, relaxation eﬀects in the ﬁrst time interval can be expected.
Especially the pattern of signiﬁcant diﬀerences for the ﬁrst time interval of
the D168V mutation is considered to be some sort of relaxation eﬀect. For
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Figure 4.21: Signiﬁcant Distance and RMSF Diﬀerences. Signiﬁ-
cant diﬀerences of average distances (solid lines), distance variances (dashed
lines) and RMSF (residue coloring) are shown at FDR tresholds 0.01 (red),
0.05 (orange) and 0.1 (yellow). The location of each point mutation under
investigation is shown as a half-transparent grey sphere. The arrangement of
ﬁgures shows from left to right the results for the ﬁrst nanosecond, nanosec-
onds 2-3 and nanoseconds 4-5 and top to bottom the mutations D168V,
R123K and I71T.
that reason, we focus on the analysis from the last time interval for all three
mutations.
Sign and extend of signiﬁcant distance diﬀerences are illustrated in ﬁgure
4.22.
D168V: In the D168V mutant, the distances from the 168-Cα atom to the
opposite β-sheet and further atoms of the active site are decreased indicating
a slight size reduction of the crevice between the two barrels. Furthermore,
some long ranged distance variances are increased.
R123K: Two distances are decreased in the R123K mutant. I refrain from
an interpretation of these because the role of the R123K mutation is more
convincingly explained in the context of substrate binding (paragraph 4.4.1).
I71T: The I71T mutation seems to loosen its local environment reﬂected by
some increased local distances. It furthermore slightly decreases the ﬂuctu-
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Figure 4.22: Sign and Extend of Signiﬁcant Distance Diﬀerences.
Sign and extend of signiﬁcant diﬀerences of average distances (solid lines)
and distance variances (dashed lines). Longer distances and higher variances
are colored blue, shorter distances and lower variances are colored red. The
width of dashes represents the extend to which the features have changed.
The location of each point mutation under investigation is shown as a half-
transparent grey sphere. The arrangement of ﬁgures shows from left to right
the results for the ﬁrst nanosecond, nanoseconds 2-3 and nanoseconds 4-5
and top to bottom the mutations D168V, R123K and I71T.
ation towards the active site reﬂected by some decreased distance variances.
Considering the time evolution, it is probable that this eﬀect would be more
pronounced if the simulations would be prolonged. The local eﬀect of I71T
is further analyzed in paragraph 4.4.3.
Distance Analysis using randomForest The same dataset that was
used for SAM can also be used as input for the machine-learning method
randomForest [174, 175]. Brieﬂy explained, randomForest classiﬁes the fea-
tures from a majority vote of an ensemble of decision tree outcomes. The
features can then be ranked by a measure indicating the importance for
the classiﬁcation result, e.g. the mean decrease Gini. Figures 4.23 and 4.24
show the results using randomForest for the D168V and I71T mutations,
66
4.4 Molecular Dynamics Study on HCV Protease
Figure 4.23: Signiﬁ-
cant distance diﬀer-
ences for the D168V
mutation using ran-
domForest. Red lines
indicate distance diﬀer-
ences at a Mean De-
crease Gini treshold of
0.28. The black ar-
row indicates the in-
duced distance shift.
Figure 4.24: Signiﬁ-
cant distance diﬀer-
ences for the I71T
mutation using ran-
domForest. Red lines
indicate distance diﬀer-
ences at a Mean De-
crease Gini treshold of
0.28. The black ar-
row indicates the in-
duced distance shift.
respectively. Only the average distances were used for this analysis.
The randomForest result for the I71T mutation shows two new signiﬁcant
distance diﬀerences that are directed towards the hairpin that coordinates
the catalytic Histidine in the active site and which were not found by SAM.
These distances are particularly interesting because they suggest a connec-
tion to the eﬀects introduced by the D168V mutation. The average dis-
tances from the D168V mutation site to the hairpin is decreased by roughly
4 nm (ﬁgure 4.23) while the average distance from the I71T mutation site
to the hairpin is increased by roughly 1 nm (ﬁgure 4.24). The full truth
concerning the compensatory eﬀect is probably quite complicated, because
the I71T/D168V double mutant is also lethal to the virus and the role of
the R123K mutation with regard to the I71T mutation remains unclear.
The two mutations D168V and R123K probably have an eﬀect that slightly
modulates substrate binding and this together with the distance shift eﬀects
described here could possibly yield a functioning protease.
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Signiﬁcant diﬀerences between apo and holo structures The SAM
analysis has also been performed for a comparison of apo versus holo sim-
ulations (ﬁgure 4.25). This analysis was performed only with short and no
long ranged distances and no distance variances. It is clear that substrate
binding induces relatively large structural changes. Hence, this comparison
may serve as a proof of concept. SAM clearly detects structural changes
that are induced by the binding of the substrate. Importantly, this test case
shows that signiﬁcant RMSF diﬀerences are also reliably detected if present.
Figure 4.25: Sig-
niﬁcant Distance
and RMSF diﬀer-
ences - Apo versus
Holo. Signiﬁcant
diﬀerences of average
distances (solid lines)
and RMSF (residue
coloring) are shown
at FDR tresholds 0.01
(red), 0.05 (orange)
and 0.1 (yellow). The
substrate is colored
cyan.
Signiﬁcant DiCC diﬀerences Signiﬁcant diﬀerences of concerted mo-
tions were analyzed by a SAM analysis on DiCC [94] values. The result for
I71T is illustrated in ﬁgure 4.26. It can be seen that there are only few dif-
ferences at FDR rates up to 0.1. With increasing FDR rate up to 0.7, there
are many more signiﬁcant diﬀerences that have reasonable reference to I71T.
The result suggests that the concertedness of motions is increased between
these residues. It is however decreased for some residues in the location of
the resistance mutations. Only the diﬀerence colored red is signiﬁcant at a
FDR rate 0.7 and the other two (colored orange and yellow) were manually
added to check if these are also in the same location. This is true only for the
orange one. The yellow one might be a false positive. Generally, it is surpris-
ing that these DiCC diﬀerences are detected while there are no observable
diﬀerences in the residue RMSFs.
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Figure 4.26: Signiﬁcant DiCC diﬀerences. The top left ﬁgure shows
signiﬁcant DiCC diﬀerences at FDR rates 0.05 and 0.1 in orange and yel-
low, respectively. The top right ﬁgure shows additional signiﬁcant DiCC
diﬀerences at a FDR rate 0.7 colored wheat. The bottom right ﬁgure shows
decreased DiCC diﬀerences in blue and increased DiCC diﬀerences in red,
orange and yellow. The bottom left ﬁgure shows corresponding SAM plot.
Local eﬀect of the I71T mutation Threonine 71 atoms OG1 and HG1
introduce both a H-bond acceptor and donor into the system (ﬁgure 4.27).
From visual inspection of the trajectories it is obvious that these two atoms
vividly change their interaction partners and the bond between Gly69-O and
Ser66-HG tends to break. To grasp this quantitatively the bond breakage and
formation of this bond was measured. This bond is present in both systems
with and without the I71T mutation and can therefore be compared. A
distance cutoﬀ was set to 3 Å and the number of formations counted. It
turns out that bond breakage and formation is 6-fold increased for the 71T
systems.
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Figure 4.27: Bond Breakage and Formation induced by the I71T
Mutation. Right) Hydrogen bond acceptors and donors. Left) Distance
time series of the bond between Gly69-O and Ser66-HG for all systems with
I71 (black) and 71T (red).
4.4.4 Conclusion
Using a multiple testing approach, SAM or randomForest, on ensembles of
trajectories revealed at least some indications of local and long range ef-
fects for the I71T mutation. However, no satisfactory explanation for its
lethal or ﬁtness-increasing eﬀects can be derived from this analysis. The
synergistic eﬀect of all three mutations might be too subtle to be equili-
brated by simulations of 5 ns length. Therefore, longer simulations would be
needed. Roughly four times more simulations would be needed to perform
comparisons between pairs of the eight mutational species to yield compara-
ble informations as when comparing simulation sets with and without one of
the mutations. An attempt to bootstrap the data resulted in a large number
of false positives.
Generally, my impression is that a few microseconds of data would be suﬃ-
cient to yield a more detailed explanation. Sets of 50 times 10 ns for each
species would probably be suﬃcient. For the eight species, simulation time
would some up to 4 microseconds for the apo state and 8 microseconds if an
analysis of the holo state would be included. This is roughly ten times more
simulation time that has been used for the present analysis.
This study has at least shown that a multiple testing approach on simu-
lation ensembles improves the detection of mutation induced geometric fea-
tures compared to analysis of data from only one simulation for each system.
The reason for this is that snapshots taken from one simulation are highly
correlated even after 10 nanoseconds [120]. Several short simulations diﬀer-
entially perturbed by diﬀerent initial conditions yield a more diverse set of
snapshots. Therefore, false positives in regions with high thermal motions
are suppressed.
It is certainly disadvantageous that for computational reasons the choice of
distance subsets was restricted to these relatively narrow distance intervals.
Increasing the ranges of these intervals or ideally analyzing all distances
would give a clearer picture of induced geometric diﬀerences. Regarding
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the problem of equilibrating eﬀects of modelled point mutations when using
multiple simulations, it would probably be a good idea to run a smaller
number of longer master trajectories that initially equilibrate these eﬀects
and start the multiple simulations from the last snapshots of these master
trajectories.
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Future Directions
MMPBSA has often been regarded as a suitable trade-oﬀ between accuracy
and eﬃciency for binding aﬃnity calculations because only end states have
to be simulated. However, a correct ranking of binding aﬃnities is typically
not obtained using conventional MD mainly because a Boltzmann-averaged
ensemble is not achieved. The usefulness of more advanced sampling algo-
rithms such as accelerated molecular dynamics (aMD) or free energy guided
sampling (FEGS) for MMPBSA calculations has not been explored yet and
this will have to be assessed in the future. Given the fact that an ensemble of
simulations is needed to yield suﬃcient sampling to get free energy estimates
converged with respect to varying initial conditions, the computational ef-
fort that has to be undertaken approaches or even exceeds that of rigorous
energy calculations. Rigorous free energy calculations on the contrary have
the potential to determine relative free energy diﬀerences induced by point
mutation quite precisely. As a consequence, rigorous methods have to be
preferred if the introduced diﬀerences are small, - this is expected for numer-
ous relevant mutations altering the binding energy of a protein receptor to
inhibitors. In the last years, the Bennett Acceptance Ratio method (BAR)
[176] has found its way to free energy calculations of biomolecules [177]. It
has been proven to be the most eﬃcient scheme to estimate the free energy
from lambda-perturbed molecular dynamics simulations and is expected to
replace TI on the long run. Compared to TI, fewer lambda steps are needed
for convergence and furthermore, BAR has an intrinsic error estimate.
Given that a high amount of simulation data is needed for both free energy
calculations and to accurately derive geometric eﬀects of point mutations,
a possible perspective would be to do both calculations on the same data.
A comprehensive strategy for the investigations of resistance mutations on
both an energetic and geometric basis could be as follows: First, a BAR
calculation could be performed to calculate the free energy diﬀerence be-
tween wildtype and mutant inhibitor complexes. For further analysis, the
correct determination of the free energy diﬀerence should be a precondition.
It is assumed, that if the free energy diﬀerence comes out right, the geomet-
ric rearrangement introduced by the mutation is correctly simulated over
the alchemical transformation path. Subsequently, geometric features, e.g. a
distances, RMSF or DiCC values could be analyzed over the transformation
path. To do so, distance distributions from all lambda steps could be eval-
uated with corresponding averages and standard deviations. The distance
data could then be analyzed comparable to a multiple testing approach.
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